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ABSTRACT 
 Walking while reducing blood flow to and from the working muscles has been 
shown to result in strength gains and increased muscle cross-sectional area (MCSA) in 
young men and older adults.  However, little is known about the effects of this type of 
novel exercise on bone metabolism and bone health.  PURPOSE:  To determine the 
effects of 12 weeks of low-intensity treadmill walking with and without blood flow 
restriction (BFR) on serum markers of bone metabolism in college-aged women.  
Secondary objectives were to examine changes in thigh and calf MCSA, muscle 
strength, aerobic capacity, and bone characteristics of the tibia following the 
intervention.  METHODS: Thirty-one young women, aged 18 to 30 years, were 
randomly assigned to one of three groups: low-intensity treadmill walking control 
(WALK) (n=10), low-intensity treadmill walking with blood flow restriction (BFR) (n-
11), or a non-exercise control group (CON) (n=10).  Subjects in the BFR and WALK 
groups walked on a treadmill at a speed associated with 45% VO2peak for up to 20 
minutes four days per week for 12 weeks.  The BFR group wore 5 cm wide 
electronically monitored elastic pressure cuffs around their upper thighs during walk 
training.  BFR cuffs were inflated to an initial pressure of 140 mmHg for the first four 
weeks, and then increased by 20 mmHg at week five (160 mmHg) and again at the start 
of week nine (180 mmHg).  The CON group was asked not to change their normal 
physical activity levels or dietary habits over the duration of the training period.  
Baseline and post-testing measurements included blood sampling for the assessment of 
bone-specific alkaline phosphatase (Bone ALP) and tartrate-resistant acid phosphatase 
isoform 5b (TRAP5b); one repetition maximum (1RM) and maximal voluntary 
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contraction (MVC) strength testing for knee extension and flexion; graded treadmill 
exercise test (GXT) for the determination of VO2peak; dual energy x-ray absorptiometry 
(DXA) to measure areal bone mineral density (aBMD) and body compsition; and 
peripheral Quantitative Computed Tomography (pQCT) to measure volumetric bone 
mineral density (vBMD) and bone area of the tibia as well as MCSA of the thigh and 
calf.  RESULTS: A significant group x time interaction occurred for Bone ALP 
(p=0.02), as serum concentrations of Bone ALP were reduced in both BFR (-5.8%) and 
CON (-9.7%) groups post-training.  Serum levels of TRAP5b and the ratio of Bone 
ALP to TRAP5b did not significantly change post-training. A significant group x time 
interaction was found for body weight (p=0.034).  However, follow up analyses failed 
to find post-training group differences or within group changes over time (p>0.05).  
After analyzing percent change in body weight from baseline, significant group 
differences were observed between BFR (-0.8%) and WALK (2.4%) groups (p=0.046).  
A significant time effect (p=0.02) and group x time interaction (p=0.002) was observed 
for MCSA at the tibia 66% site.  Follow up analyses revealed that MCSA significantly 
increased from baseline in both BFR (1.8%) and WALK (3.6%) groups (p<0.05).  
Significant time effects were found for MVC knee extension strength at joint angles of 
30 degrees (p=0.02) and 60 degrees (p=0.004), with no differences between groups.  A 
significant group x time interaction occurred for 1RM knee extension strength 
(p=0.014), with follow up analysis revealing a significant (p=0.026) increase in strength 
in the BFR group (4.5%) post-training.  Significant main effects for time were found for 
trabecular bone content (p=0.036) and trabecular vBMD (p=0.024) at the tibia 4% site, 
both of which decreased over the study duration.   Significant time effects were also 
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found for total bone content (p=0.036) and SSI (p=0.011) at the tibia 38% site as well as 
total bone content (p=0.043), total vBMD (p=0.029), total bone area (p=0.001), 
periosteal circumference (p=0.002), and endosteal circumference at the 66% site.  Total 
vBMD at the 66% site decreased post-training, whereas the other variables with 
significant time effects increased over the study duration.  CONCLUSION: Twelve 
weeks of walking with BFR resulted in reduced levels of bone formation with no 
change in bone resorption in young women.  Additionally, BFR walking resulted in 
favorable neuromuscular changes.            
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CHAPTER I 
INTRODUCTION 
 Osteoporosis, a disease of the skeleton characterized by decreased bone mass 
and strength with an increased risk for fragility fracture,  is a serious public health 
problem with debilitating effects on health and daily function (56).  In the United States, 
over 50% of women aged 85 years or older have osteoporosis (37). Osteoporosis is 
attributed to over 1.5 million fractures per year which result in 800,000 emergency 
room visits, 500,000 hospitalizations, 2.6 million physician visits, 180,000 nursing 
home placements, and up to $18 billion in healthcare costs each year (37).  Following a 
hip fracture, the one-year mortality rate for individuals over the age of 50 has been 
estimated to be as high as 10-15 percent (67, 87).  It has also been estimated that by the 
year 2020, over 14 million individuals will be osteoporotic and 47 million will be at risk 
for osteoporosis (38).  As the population is living longer, there is increased demand for 
discovery of ways to prevent osteoporosis and the fractures associated with the disease. 
The discovery of new interventions to increase bone mass, especially in young adult 
women, may reduce the health care costs and increase quality of life in the 
postmenopausal years when osteoporosis is most prevalent.  
 Osteoporosis is diagnosed based on an individual’s areal bone mineral density 
(aBMD).  Areal BMD is the amount (grams) of bone mineral content (hydroxyapatite) 
per area of bone (cm2) and has been shown to account for nearly 55-80% of whole bone 
strength (5).  Areal BMD of the whole body, femur, lumbar spine, and radius can be 
determined by dual energy x-ray absorptiometry (DXA), which is a type of low-dose x-
ray machine.  The World Health Organization has developed a classification system for 
2 
 
the diagnosis of osteoporosis based on an individual’s T-score, or the number of 
standard deviations the aBMD falls in relation to the average aBMD of a healthy 
Caucasian young adult female (52).  A T-score of -2.5 or less, or 2.5 standard deviations 
below the young adult female average, is the clinical criterion for diagnosis of 
osteoporosis.  Areal BMD has been shown to decline after menopause, and this bone 
loss has been closely associated with a decrease in circulating estrogen levels and an 
overall increase in bone turnover (26). 
Bone turnover, or bone remodeling, is the metabolic process responsible for 
continuous renewal of bone to maintain mechanical integrity of the skeleton as well as 
aid in mineral homeostasis (44).  Bone remodeling is achieved through a tightly coupled 
process of bone resorption and bone formation by the bone basic multicellular unit 
(BMU).  Osteoclasts are responsible for the bone resorption phase and act to break 
down mineralized bone tissue.  This is followed by differentiation and activation of 
osteoblasts, which serve to lay down new bone tissue followed by complete 
mineralization.  Bone remodeling is hormonally and mechanically regulated.  
Parathyroid hormone (PTH), calcitonin, and 1,25-dihydroxyvitamin D3 (Vitamin D) 
directly and indirectly act to modulate bone remodeling to maintain serum calcium 
levels at 8.5-10 mg/dl (114).  Parathyroid hormone is secreted in response to low levels 
of serum calcium and acts to increase bone resorption.  In contrast, calcitonin is secreted 
in response to elevated levels of serum calcium and acts to decrease osteoclastic bone 
resorption, thus maintaining calcium homeostasis. 
Mechanical loading is essential for proper bone growth and maintenance of 
skeletal integrity. Mechanically mediated bone turnover promotes site-specific 
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activation of the BMU to undergo adaptive changes and to repair damage.  Increasing in 
vivo and in vitro evidence suggests that osteocytes are responsible for sensing bone 
strain caused by mechanical loading and subsequently relay these strains to activate 
other bone cells biochemically (49).  According to Frost (32), bone modeling and 
remodeling are controlled by several mechanical thresholds where bone is either taken 
away, maintained, or added in order to meet the mechanical demands placed upon it.  In 
this light, Frost alluded to the importance of the muscle and bone relationship, where he 
suggested that the largest strains on bone are derived from muscle contractions.  In this 
regard, exercise that increases muscle strength and size should also influence bone 
metabolism and bone health. 
Bone metabolism is a dynamic process, that when altered, can lead to bone loss 
or bone gain.  The development of assays that measure biochemical bone turnover 
markers (BTM’s) in serum or urine provide a dynamic view of the remodeling process.  
Their use in clinical settings has become valuable for monitoring treatment of 
osteoporosis as well as predicting long-term BMD changes (8, 42).  Recently, BTM’s 
have been used in predicting the long-term osteogenic potential of different types of 
exercise. 
It has been appreciated for some time that mechanical loading through exercise 
positively affects bone mass.  While peak bone mass has several determinants (lifestyle, 
genetics, etc.), it is generally accepted that mechanical loading during adolescence and 
early adulthood is critical for developing and maximizing peak bone mass, which 
subsequently helps to prevent bone loss later in life (78).  Data from longitudinal studies 
investigating the efficacy of exercise to increase bone mass in young premenopausal 
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women have led the American College of Sports Medicine to recommend two general 
modes of exercise for bone health:  high-impact exercises resulting in increased ground 
reaction forces (GRF’s), and high-intensity resistance training (57). Generally, 
longitudinal studies employing progressive, high-intensity resistance training as well as 
high-impact aerobic-type exercises such as hopping and jumping have reported modest 
1-3% increases in aBMD of the spine and/or hip in premenopausal women (57).  The 
positive benefits of these types of exercise have also been alluded to in studies 
examining the effects of exercise on bone turnover markers.  In a recent study by Lester 
et al. (68), increased levels of the bone formation marker, bone-specific alkaline 
phosphatase (Bone ALP), were reported in college-aged women after either eight weeks 
of high-intensity resistance training or resistance training combined with an aerobic 
program that included moderate to high-intensity jogging and interval running. In 
contrast, no changes in Bone ALP were seen in the aerobic-only group.   
Recently, a novel form of training which involves the use of low-intensity 
exercise while restricting blood flow to the working muscle has been shown to increase 
muscle size and strength similar to that of traditional high-intensity resistance training 
(77).  Blood flow restriction (BFR) training, also known as KAATSU training, involves 
the use of an electronically monitored and controlled pneumatic air pressure cuff which 
is placed around the most proximal portion of either the arms or legs and inflated during 
exercise.  Most often, BFR cuffs have been used in conjunction with low-intensity (20-
50% 1RM) resistance training and more recently, treadmill walking.  Abe and 
colleagues (1) reported a significant increase in quadriceps and hamstring muscle cross-
sectional area (MCSA) as well as dynamic and isometric knee extensor strength after 
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only three weeks of twice daily treadmill walking with BFR in college-aged men.  
Similar results were also found in older adults after 10 weeks of walking with BFR for 
20 minutes per day (2).   While the beneficial neuromuscular effects of this type of 
training are promising, little is known about the potential effects it may have on bone.   
To date, one study has examined the effect of walking with BFR on BTM’s in 
college-aged males.  After three weeks of twice daily walking with blood flow 
restriction, resting levels of the bone formation marker Bone ALP were significantly 
elevated (10).  This change was not observed in the control group who performed the 
same walking protocol but without BFR.  Interestingly, this form of training does not 
meet the current criteria recommended by the American College of Sports Medicine for 
maintaining bone health (57).  A low-intensity, functional type of exercise such as 
walking combined with BFR may provide an attractive alternative for individuals not 
able to perform the type of exercise currently recommended for bone health.  However, 
the effects of walking with BFR on bone metabolism are not well described, and 
therefore, more evidence is needed to recommend its use.    
Purpose 
 The purpose of this study was to examine the effects of 12 weeks of treadmill 
walking with and without blood flow restriction on biochemical markers of bone 
turnover in college-aged women.  A secondary purpose was to examine changes in 
thigh and calf MCSA, muscle strength, aerobic capacity, and bone characteristics of the 
tibia following the intervention. 
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Research Question 
1. Will 12 weeks of treadmill walking with and without blood flow restriction 
significantly alter the resting serum levels of the bone turnover markers bone-
specific alkaline phosphatase (Bone ALP) and tartrate- resistant acid 
phosphatase isoform 5B (TRAP5b)? 
Hypothesis 
1. Twelve weeks of treadmill walking with blood flow restriction but not without 
will result in significantly elevated levels of Bone ALP.  Resting levels of 
TRAP5b will not change following 12 weeks of treadmill walking with or 
without blood flow restriction. 
Subquestions 
1. Will 12 weeks of walking with and without blood flow restriction result in 
increased thigh and calf MCSA and leg bone free lean body mass?  
2. Will 12 weeks of walking with and without blood flow restriction result in 
increased lower body strength? 
3. Will 12 weeks of walking with and without blood flow restriction result in 
increased aerobic capacity? 
4.  Will 12 weeks of walking with and without blood flow restriction result in 
significant changes in bone characteristics of the tibia? 
Subhypotheses 
1. Twelve weeks of walking with blood flow restriction will result in increased calf 
and thigh MCSA and leg bone free lean body mass, with no changes occurring 
from walking without blood flow restriction. 
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2. Twelve weeks of walking with blood flow restriction will result in increased 
lower body strength, with no changes occurring from walking without blood 
flow restriction. 
3. Twelve weeks of walking with blood flow restriction will result in increased 
aerobic capacity but will remain unchanged following 12 weeks of walking 
without blood flow restriction. 
4. Twelve weeks of walking with blood flow restriction will result in positive bone 
adaptations at the distal tibia site with no change after 12 weeks of walking 
without blood flow restriction. 
Significance 
 Walking with BFR has already been shown to provide beneficial neuromuscular 
adaptations in young men (1) and the elderly (2), and there is some evidence from a 
short-term (3 weeks) study of walking with BFR in young men that suggests favorable 
alterations in a bone formation marker (10).  From what is currently known, high-
impact activities such as jumping and high-intensity resistance training are thought to 
provide the most benefit to bone (57).  However, these forms of training may not be 
appropriate for some populations.  Walking is a very functional form of exercise that 
can be done by a wide range of individuals.  If walking with BFR were to show a 
favorable change in the bone metabolic profile, it would provide an attractive 
alternative for individuals at risk for low bone mass, older adults, individuals recovering 
from injury/illness, and astronauts. However, in the current state, too few data exist to 
recommend its use.  
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Assumptions  
1. All subjects gave maximal effort during baseline and post-testing. 
2. Subjects did not exercise 48 hours prior to and were fasted overnight before 
baseline and post-training blood draws. 
3. All subjects were taking oral contraceptives at the start and throughout the 
duration of the study. 
4. Subjects in the non-exercise control group maintained their current level of 
physical activity throughout the study period and both exercise groups only 
participated in the exercise prescribed to them by the researchers. 
5. Subjects answered questionnaires truthfully. 
Delimitations   
1.  The findings of this study are only applicable to young women taking 
combination oral contraceptives. It is possible that the effects of exercise on 
BTM’s could be different for non-oral contraceptive users, as combination oral 
contraceptives have been shown to alter bone metabolism. 
2. Subjects are free of any physical or medical problems limiting them to exercise 
such as osteoarthritis, musculoskeletal injury, and/or cardiovascular disease.   
3. Subjects are not currently active, defined as not doing structured exercise more 
than two days per week for the last three months. 
Limitations 
1. Exercise outside of the training program was not strictly monitored.  However, 
all groups were asked not to participate in any exercise outside of the program 
and were reminded periodically throughout the intervention. 
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2. It is possible that sunlight exposure could have affected bone marker 
concentrations. 
3. Combination oral contraceptive use throughout the study may have stopped or 
contraceptive method may have changed.  However, in order to monitor oral 
contraceptive use, a simple questionnaire was given to each participant during 
each exercise session. 
4. It is possible that weight loss may have occurred over the 12-week training 
period, which could affect some of the results including serum markers of bone 
turnover.  A self-reported 3-day food log was used to monitor nutrient intake at 
baseline (week 1) and post-training (week 12). Vitamin supplementation was not 
monitored by the 3-day food log.  Additionally, participants were asked not to 
purposely reduce their caloric intake or change their normal dietary patterns 
over the intervention period. 
5. It is possible that bone marker concentrations were affected by normal diurnal 
rhythms.  However, blood samples were obtained between 8:00 and 10:00 AM 
on both baseline and post-training collection days to minimize this effect.  
6. Owing to the total length of the study and the time of year that it commenced, 
seasonal variation could affect serum bone marker concentrations.    
Operational Definitions 
Areal bone mineral density (aBMD) - The total grams of bone mineral per unit of bone 
area (g/cm
2
), commonly assessed by dual energy x-ray absorptiometry. 
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Blood Flow Restriction training (BFR) - The use of an electronically monitored and 
controlled pneumatic air pressure cuff which is placed around the most proximal portion 
of an appendicular limb and inflated during exercise, also known as KAATSU training. 
Bone-specific Alkaline Phosphatase (Bone ALP) - A bone-specific isoenzyme of 
alkaline phosphatase produced by the osteoblast.  The function of bone alkaline 
phosphatase is not clearly understood, but it is thought to be involved in bone 
mineralization process (88).  
Bone mineral content (BMC)--The total grams (g) of bone mineral within a scanned 
region 
Bone Modeling – A process by which bone grows and becomes stronger through 
organized bone cell activity of osteoblasts and osteoclasts. It increases bone strength by 
increasing or adding mass and improving the existing geometry (88). 
Bone Remodeling – The metabolic process mediated by osteoclasts and osteoblasts to 
renew bone and repair microdamage (88). 
Dual Energy X-ray Absorptiometry (DXA) - Bone measurement modality that uses two 
contrasting x-ray beams to yield a two-dimensional representation of the skeleton. DXA 
calculates the attenuation values of photons that pass from the x-ray tube through the 
measurement site of interest. Outcome variables include bone mineral content (BMC) 
and areal bone mineral density (aBMD).  
High-impact loading - Characterized by both high-rate and high-magnitude loading 
such as that experienced by bone during jumping and hopping, etc.    
Mechanical Loading - Refers to the applied forces placed on the skeleton or individual 
bones via forms of physical movement or activity (33). 
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Oral Contraceptives – Also known as the birth control pill. Oral contraceptives are 
either a combination of estrogen and progestins or progestins alone in pill form used to 
inhibit ovulation by reducing the natural fluctuation of estrogen and progesterone 
hormones during the menstrual cycle.   
Osteoblasts - Bone cells responsible for bone formation. Produce a bone matrix 
composed of collagen and other substances that ultimately becomes calcified (88). 
Osteoclasts - A multinucleated bone cell responsible for the resorption of bone (88). 
Osteoporosis - A disease of the skeleton characterized by low bone mineral density and 
micro-architectural deterioration, leading to bone fragility and increased risk of fracture 
(33). 
Peripheral Quantitative Computed Tomography (pQCT) - Bone measurement modality 
that provides a three-dimensional representation of a particular site of interest. Measures 
the attenuation of radiation as it passes from the source to the site of interest. Outcome 
measures include BMC, vBMD, bone and muscle cross-sectional area, and bone 
thickness.  Unlike DXA, pQCT has the ability to differentiate between types of bone 
and may be more sensitive to changes in bone due to physical activity (75). 
Premenopausal - Women that have regular menstrual cycles that have not changed 
recently in duration (41). 
Repetition maximum (RM) – A neuromuscular strength test usually assigned a specific 
number of repetitions i.e. 1RM, 5RM. The maximal weight at which an individual can 
produce a successful lift or lifts through the full joint range of motion.  
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Tartrate-Resistant Acid Phosphatase isoform 5b (TRAP5b) - Is typically expressed in 
mature osteoclasts and is proportionate to osteoclast activity as well as representative of 
osteoclast number (88). 
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CHAPTER II 
LITERATURE REVIEW 
Introduction  
 Osteoporosis is a bone disease characterized by low bone mass and micro-
architectural deterioration resulting in bone fragility and an increase in the susceptibility 
for trauma-induced fracture (45).  Essentially, osteoporosis manifests as a silent disease 
until an osteoporotic fracture occurs.  According to the Surgeon General (38), four out 
of ten women over the age of 50 will experience an osteoporotic fracture of the hip, 
spine, or wrist and the overall incidence of osteoporotic fractures are on the rise. 
Osteoporotic fractures are a serious and life-threatening problem. Approximately one in 
five patients over the age of 50 who experience hip fracture will die within one year 
(74) and one third of those who experience hip fracture will require nursing home 
assistance (60).  Besides the devastating clinical consequences to the patient and their 
family, osteoporotic fractures also result in a substantial financial burden.  It has been 
estimated that the direct costs associated with osteoporotic fractures is approximately 17 
billion per year with projections close to 40 billion by the year 2040 (60).   
 At menopause, cessation of sex hormone production is associated with an 
increase in bone turnover and accelerated bone loss in women.  Because low peak bone 
mass is a risk factor for osteoporosis, it is generally accepted that maximizing peak 
bone mass through adequate nutrition and physical activity in the adolescent and early 
premenopausal years may help to prevent bone loss associated with the menopause 
(60). In this regard, exercise interventions that result in favorable bone adaptations in 
premenopausal women could potentially help to decrease the occurrence of osteoporosis 
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and osteoporosis-related fractures later in life.  Currently, exercise resulting in high 
ground reaction forces as well as high-intensity resistance training is recommended for 
bone health (57).  However, these types of exercise may not be appropriate for all 
individuals, especially those with already low bone mass or recovering from a de-
conditioned state.  
 This literature review will examine bone structure and physiology with emphasis 
on the remodeling process and its regulation, mechanical loading and bone 
mechanotransduction mechanisms, biochemical markers of bone turnover, the effects of 
exercise on biochemical markers of bone turnover and aBMD in premenopausal 
women, as well as a novel form of exercise training which may have important 
implications for bone health.   
Bone Structure and Physiology 
 The skeleton is a remarkable organ that fulfills multiple functions including 
support and protection of vital organs, acting as a lever for locomotion, and is the 
largest storage for calcium and phosphate needed for the maintenance of mineral 
homeostasis. Approximately 70% of bone is composed of inorganic and 30% organic 
material (88). The vast majority of the organic matrix consists primarily of Type I 
collagen fibers and non-collagenous proteins. Also included in the bone matrix are 
several types of bone cells, cytokines, and growth factors which are necessary for 
maintaining bone homeostasis. The inorganic portion of bone is composed primarily of 
hydroxyapatite crystals [Ca10(PO4)6 (OH)2] which precipitates on the organic matrix 
providing bone with its structural rigidity and strength (114). Together, the organic and 
inorganic components combine to form two main types of bone. 
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The majority of the human skeleton is composed of the dense cortical bone 
while the more porous trabecular bone only accounts for about a fifth of the total 
skeleton (16).  However, different bones will have different ratios of cortical and 
trabecular bone dependent on the bone’s primary function. While cortical and trabecular 
bone contain the same general components, their structure, mechanical and metabolism 
are inherently different.  Cortical bone is dense and compact and is resistant to bending 
and torsional forces (44).   These characteristics are in part due to its structural design.  
The haversian system of cortical bone is composed of several layers of densely packed 
concentric lamellae which form a cylindrical canal that houses vessels, nerve, 
connective tissue, and bone cells (114).  Trabecular bone is less dense but more elastic 
than cortical bone. It consists of vertical and horizontal lamellae that form a latticework 
of struts shaped as plates and rods.  This design allows trabecular bone to resist 
compressional forces by distributing the stress throughout the latticework (22).  
Trabecular bone has a large surface area accessible to osteoclastic resorption and is 
metabolically more active in the maintenance of bone mineral homeostasis than cortical 
bone (88).  
Bone is a dynamic and active tissue that undergoes continuous turnover, repair, 
and structural micro-cellular change throughout the lifespan.  It is estimated that about 
10 percent of the human skeleton is renewed every year through bone remodeling (114).  
Bone remodeling is achieved by a temporary bone structure called the basic 
multicellular unit (BMU).  Each BMU consists primarily of the bone resorption cells 
osteoclasts and bone formation cells osteoblasts.  Osteocytes, which are differentiated 
mature osteoblasts, are also involved in the remodeling process.  Osteoblasts are derived 
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from undifferentiated mesenchymal stem cells (MSC).  Their differentiation from 
MSC’s to pre-osteoblasts and ultimately mature osteoblasts require the coordinated 
interaction of multiple endocrine, paracrine, and autocrine factors (18). Pre-osteoblasts 
as well as mature osteoblasts have several important roles in the remodeling process 
including expression and regulation of osteoclastogenic factors, production of bone 
matrix proteins, and bone mineralization (90). Osteoclasts are large multinucleated bone 
cells responsible for the bone resorption phase in bone remodeling. Osteoclast precursor 
cells differentiate from hematopoietic stem cells and are of the monocyte-macrophage 
lineage (16). Two local cytokines are responsible for osteoclast differentiation including 
Macrophage Colony Stimulating Factor (M-CSF) and receptor activator of NF-kB 
ligand (RANKL). M-CSF is essential for the proliferation, differentiation, and survival 
of osteoclast precursor cells (16). RANKL belongs to the tumor necrosis factor (TNF) 
receptor super family and is critical for terminal differentiation of osteoclast precursors 
to mature osteoclasts (66).  Osteoclasts secrete hydrogen ions as well as collagenolytic 
enzymes to aid in the breakdown and digestion of the bone matrix during bone 
resorption (16).  Osteocytes are terminally differentiated osteoblasts that become 
engulfed in the unmineralized osteoid matrix during bone deposition.  They account for 
90-95% of all bone cells.  Osteocytes are housed in fluid-filled cavities within the 
mineralized matrix called lacunae and have dendritic processes that extend through tiny 
canals called canaliculi which allow direct interaction with other osteocytes, osteoblasts 
on the bone surface, and bone precursor cells in the marrow (12).  Due to their ubiquity, 
location, and extensive dendritic network, osteocytes are thought to be the bone cell 
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responsible for sensing mechanical strain and converting it to a useful biochemical 
signal for the (re)modeling process (12).    
Bone remodeling/turnover is the process by which bone is renewed to maintain 
skeletal strength and regulate mineral homeostasis.  Four distinct phases encompass 
bone remodeling: activation, resorption, reversal, and formation.  Together, these 
phases occur over a 3-6 month span (16). The activation phase involves exposing the 
bone surface for osteoclast attachment as well as recruitment of preosteoclasts to the 
resorption site.  Once at the resorption site, preosteoclasts anchor to adhesion sites 
within the exposed bone matrix and start the resorption process.  The resorption phase 
involves proliferation, differentiation, and activation of mature osteoclasts by 
osteoblastic regulatory factors (44).  The osteoclast forms a sealing zone along the bone 
surface and secretes hydrogen ions which mobilize bone mineral.  The remaining 
organic matrix is degraded by the osteoclastic secreted enzymes cathepsin K and 
tartrate-resistant acid phosphatase (90).  Following osteoclast-mediated resorption, the 
reversal phase acts to prepare the newly resorbed bone surface for bone deposition by 
osteoblasts.  This preparation is accomplished, in part, by a “reversal” cell whose 
lineage has yet to be identified (90).  The final phase of bone remodeling is formation of 
newly synthesized bone.  Preosteoblast cells are recruited to the resorption pit to 
undergo differentiation into mature osteoid-secreting osteoblasts (44).  Mature 
osteoblasts synthesize and secrete type I collagen along with other bone matrix proteins 
which fill the resorption cavity.  This is followed by mineralization within and around 
the newly formed osteoid matrix.  
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The regulation of bone remodeling is mediated either directly or indirectly by 
the actions of several hormones. A serum calcium level of 8.5-10 mg/dl is tightly 
regulated by the secretion of parathyroid hormone (PTH), calcitonin, and vitamin D 
(114).  When serum calcium levels are suppressed, calcium sensitive receptors on the 
parathyroid cell membrane respond by signaling an increase in secretion of PTH (13). 
In an attempt to increase serum calcium, PTH exerts its effects on the bones, kidneys, 
and intestine. In bone, PTH receptors are expressed by osteoblasts and osteocytes and 
activation of the receptor by PTH increases the expression of the osteoclastic regulator, 
RANKL (114). Increased expression of RANKL results in activation of osteoclasts to 
increase bone resorption resulting in extracellular calcium release. When serum calcium 
levels become too high, calcitonin is secreted from the C cells of the thyroid gland 
which targets bone and kidneys.  In bone, calcitonin acts directly on osteoclasts by 
causing loss of the ruffled border and its capacity to secrete degradation enzymes(14).  
Ultimately, calcitonin acts to decrease bone resorption.     
It is well known that estrogen and its receptors play an important role in the 
regulation of bone remodeling and that the loss of estrogen during the menopause 
results in increased bone resorption and subsequent bone loss (125).  However, the 
exact mechanism(s) by which estrogen exerts its positive bone effects are still under 
intense investigation.  Generally, estrogen has an effect on cell viability.  There is 
evidence that suggests estrogen promotes osteoblast and osteocyte survival as well as 
apoptosis and anti-proliferation of osteoclasts (125).  Nakamura et al. (80) have recently 
shown that female mice with selective knockout of the osteoclast estrogen receptor 
alpha (ERalpha) have greater trabecular bone loss compared to their wild type 
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counterpart due to increased osteoclastogenesis and thus bone resorption.  In addition, 
the administration of estrogen in the ERalpha knockout mice did not result in bone 
recovery.  Besides the effects of estrogen on cell viability and apoptosis, It has also 
been suggested that estrogen acts to determine the “set point” for the bone response to 
mechanical loading (33).  Work by Devlin and Liberman (21) has shown that young 
sheep administered different levels of estrogen have a dose-dependent response of bone 
growth when exposed to the same exercise regimen.  Specifically, sheep administered a 
high dose of estrogen had greater bone accrual after 45 days of exercise than did sheep 
with normal estrogen or decreased estrogen levels.  In support of these data, Lanyon’s 
group (65) has shown that wild-type mice have a three-fold greater bone growth 
response to ulnar mechanical loading than their ERalpha knockout counterparts.  In cell 
culture studies, Lanyon (65) has also shown that osteoblast-like cells deficient in 
ERalpha have reduced proliferative capacity after being subjected to mechanical 
stretching.  More recently, Lanyon’s group (61) has shown that ERalpha aids in the 
shuttling of beta-catenin into the nucleus during mechanotransduction, thereby 
increasing activation of the Wnt/beta-catenin bone formation pathway.   
 Mechanical Loading  
Mechanical loading of bones is vital for normal skeletal maturation and for 
maintaining bone strength throughout the lifetime (34).  Mechanically mediated bone 
turnover promotes site-specific activation of the BMU to undergo adaptive changes and 
to repair damage.  The importance of skeletal loading has been appreciated for some 
time, as Julius Wolff in the late 1800’s realized that bone growth and remodeling 
seemed to be in response to the physical demands placed upon it (120).  This 
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phenomena was expanded upon by Harold Frost (32) who proposed the “mechanostat” 
theory of bone modeling and remodeling in response to the mechanical environment.  
The mechanostat theory suggests that bone mass and structure are regulated by several 
mechanical thresholds in which mechanical signals above or below a certain threshold 
result in either bone being taken away or added.  Frost also suggested that the largest 
mechanical loads acting upon bone are from muscle contractions; hence whole bone 
strength adapts to meet the demands of increased muscle strength and size.  Frost’s 
theory has been supported by several studies that have found surrogates of muscle 
strength such as muscle cross-sectional area and appendicular bone free lean body mass 
to consistently be the best predictors of indices of bone strength (27, 73, 101).  The 
importance of mechanical loading to the skeleton has been supported by several human 
studies.  Loss of bone mass has been reported in individuals confined to bed rest (59), in 
limbs that are immobilized due to injury (117), and in astronauts exposed to weightless 
environments (64).  Alternatively, increased bone mass has been reported in the 
dominant limbs of ten-pin bowlers (124), tennis players (43), and gymnasts (121).  Most 
experimental evidence that exercise or mechanical loading can increase bone mass 
comes from controlled trials using animal models. In this regard, Turner’s (112) work 
led him to propose a set of criteria necessary for bone to respond to loading.  First, the 
loading must be dynamic, as static loads are not recognized by the mechanosensing 
machinery. Second, extending loading duration does not result in increased bone mass. 
Therefore, short duration loading periods are beneficial for bone. Lastly, the 
mechanosensing machinery accommodates to routine loading and therefore, the 
mechanical loading should deliver “abnormal” strains. While experimental animal 
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studies have confirmed these criteria, human exercise interventions to increase bone 
mass have not been as successful. One reason for this observation may be a lack of 
understanding in the exact mechanism of how bone’s mechanosensing machinery 
interprets mechanical strain and changes it to an anabolic biochemical signal.  
The location, abundance, and cell-interconnectivity of osteocytes make these 
cells an ideal candidate for transducing mechanical strain into a biochemical signal (84). 
Tatsumi and colleagues (111) recently showed that selective osteocyte ablation in mice 
resulted in osteoporosis due to faulty mechanotransduction.  Although the osteocyte is 
becoming more accepted as the mechanosensing cell in bone, the exact mechanism by 
which it responds to strain has yet to be elucidated and is an ongoing area of research.  
Most of what is known has been derived from isolated cell culture studies as well as 
theoretical mathematical modeling.  One hypothesis is that the osteocyte detects bone 
deformation via direct cellular strain from the matrix (12). The second hypothesis, 
which is becoming more accepted, is that mechanical strain on the bone generates a 
pressure gradient in which lacunar-canicular interstitial fluid is propelled from the area 
of deformation to an area of tension (31). Theoretically, the increased fluid flow from 
dynamic loading would cause fluid shear stress across either the cell body or dendritic 
processes or both (12).  While the exact mechanism is still unknown, Wang and 
colleagues (116), through examination of the lacunar-canicular system with electron 
microscopy, have proposed that the fluid shear stress activates integrins that connect the 
dendritic process membrane to the canicular wall. Wang’s elastohydrodynamic model 
for integrin-based signaling would allow for amplification of cellular-based strain. This 
is a very important feature of the model, especially since in vitro cell-strain studies 
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indicate that a strain magnitude of at least 0.5% (5000 microstrain) is required at the 
cellular level to initiate a biochemical response (123), yet whole bone strain caused by 
movement rarely exceed 0.2% (2000 microstrain) (29, 30).  Even though Wang’s 
theoretical model provides indirect evidence for the fluid flow hypothesis, direct in vivo 
evidence of increased fluid flow from external mechanical loading has been lacking.  
However, the fluid flow hypothesis was strengthened when Price and colleagues (89), 
for the first time, were able to show an increase in lacunar-canicular fluid flow from in 
vivo mechanical loading. Through fluorescence recovery after bleaching and 
synchronized mechanical loading via cyclic compression, Price and colleagues were 
able to definitively show that moderate mechanical loading increased fluid flow by 31% 
in rat tibia. Importantly, Price and colleagues also estimated that the magnitude of fluid 
shear stress produced was similar to that which triggers biochemical reactions in vitro. 
Since the isolation and establishment of osteocyte-like cells (MLO-Y4) (54), in 
vitro studies of these cells exposed to fluid shear stress have obtained some important 
data regarding biochemical pathways in the control of bone remodeling. Osteocyte-like 
cells exposed to pulsating fluid shear stress have been shown to increase expression of 
prostaglandins (PGE2) and nitric oxide (NO) as well as increased phosphorylation of 
GSK-3beta and other beta-catenin target genes involved in the Wnt/beta-catenin bone 
formation pathways (12).  In vivo studies have started to confirm these findings.  
Kramer and colleagues (58) found that osteoclast number and activity were increased in 
osteocyte-specific beta-catenin deficient mice. In addition, the RANKL/OPG ratio was 
increased and the animal’s cancellous bone mass was almost non-existent. Robling and 
colleagues (95) found that osteocyte sclerostin expression was reduced in rodent ulna 
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exposed to cyclic mechanical loading but increased expression was found in rodents 
exposed to hind limb suspension.  Sclerostin is only expressed by osteocytes and is a 
powerful inhibitor of the Wnt/beta-catenin bone formation pathway (95).  Taken 
together, these in vitro and in vivo studies provide some compelling evidence into the 
mechanisms by which osteocytes control mechanical loading-mediated bone 
remodeling. 
Biochemical Markers of Bone Turnover 
 Bone mineral density measured by DXA is considered the gold standard for 
bone health and skeletal status.  While BMD is clinically useful, it is a static 
measurement and tells us little about the dynamic process of bone turnover.  In the last 
20 years, assays capable of identifying blood serum or urine-derived biomarkers of 
bone formation and resorption have been developed.  These markers provide a dynamic 
view of the bone remodeling process and are useful in assessing the remodeling 
response to exercise and pharmacological interventions.  In general, bone turnover 
markers (BTM’s) are classified as either markers of bone formation or bone resorption. 
Bone formation markers are either direct or indirect products of osteoblast development, 
function, or mineralization (20). They include bone-specific alkaline phosphatase (Bone 
ALP), osteocalcin (OC), and N-terminal and C-terminal procollagen type I propeptides 
(PINP, PICP).  Bone resorption markers are either degradation products of bone matrix 
or enzymes secreted from osteoclasts (107). They include N and C-Terminal cross-
linking telopeptides of Type I collagen (NTX-1, CTX-1), C-terminal cross-linking 
telopeptides of type I collagen generated by metalloproteinase (ICTP), 
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deoxypyridinoline and pyridinoline (DPD, PYD) and tartrate-resistant acid phosphatase 
isoform 5b (TRAP5b).  
 In order for the use of BTM’s to be clinically useful, their change to an 
intervention should be predictive of long-term changes in BMD.  Greenspan and 
colleagues (42) conducted a three-year study on women taking hormone replacement 
therapy, alendronate, or a combination of both.  They found that women who 
experienced the greatest decreases in NTX-1 measured at 6 months also experienced the 
greatest increases in aBMD at 3 years.  Bauer et al. (8) conducted a study to investigate 
the effects of PTH treatment over one year in osteoporotic women.  Blood samples were 
obtained at baseline and at 1 and 3 months after treatment.  BMD of the spine and hip 
were determined using DXA and QCT at baseline and after one year of treatment.  
Treatment with PTH resulted in increased levels of the bone formation marker PINP as 
well as increases in volumetric BMD of the spine.  Additionally, each standard 
deviation increase in the 3-month change of PINP was associated with a 21% greater 
increase in spine trabecular vBMD.  While these studies found significant relationships 
between BTM’s and long-term changes in BMD, it must be noted that the BTM 
response is highly variable and proper care to standardize measurements must be taken.  
 BTM’s can be influenced by several biological factors including time of day 
(diurnal variation), seasonal changes (time of year), feeding status, menopausal status, 
and menstrual cycle phase (107).  Garnero and colleagues (36) conducted a study 
investigating menopausal status on multiple BTM’s of formation and resorption.  653 
women free of medications known to affect bone metabolism were separated into four 
groups based upon their menopausal status: premenopausal, perimenopausal 1, 
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perimenopausal 2, and postmenopausal.  The menopause transition resulted in a 37-53% 
increase in bone formation markers and a 79-97% increase in resorption markers. 
Additionally, these markers did not decrease with age once menopause was reached.  
The researchers concluded that a high turnover rate associated with the menopause may 
be a determinant of bone loss.  The menstrual cycle has also been shown to affect the 
levels of certain bone markers.  Zittermann and colleagues (126) measured bone 
formation and resorption markers in ten premenopausal women with normal menses 
during the 4 phases of the menstrual cycle.  They found that both formation and 
resorption markers fluctuated in a cyclic pattern.  The researchers concluded that the 
fluctuations in BTM’s were likely due to the fluctuations in estrogen throughout the 
menstrual cycle.  Oral contraceptives have also been shown to alter BTM’s.  Nappi and 
colleagues (81) conducted a 12-month randomized controlled trial on the effects of low-
dose and ultra-low-dose oral contraceptives on BTM’s and aBMD in premenopausal 
women .  Sixty premenopausal women with normal menses were randomly assigned to 
either a low-dose oral contraceptive (20 micrograms ethinyl estradiol), ultra-low-dose 
oral contraceptive(15 micrograms ethinyl estradiol), or non-contraceptive control group.  
Blood and urine samples were taken at baseline, 3, 6, 9, and 12 months and analyzed for 
OC, DPD, and PYD.  Areal BMD of the spine was analyzed at baseline and 12 months.  
Both oral contraceptive groups showed significant reductions in bone resorption 
markers at 6, 9, and 12 months compared to the control group.  No change in OC or 
aBMD was found.  Taken together, the results of these studies suggest that menstrual 
history and status, menstrual phase, and oral contraceptive use must be considered when 
measuring changes in BTM’s in women.   
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Exercise Interventions and BTM’s in Premenopausal Women  
  Interventions designed to test the efficacy of different types of exercise to 
stimulate bone formation or slow its loss typically last 6-36 months due to bone mass 
changes occurring from a slow metabolic process (57).  In this regard, testing the 
osteogenic potential of different types of exercise by measuring chronic changes in 
BTM’s is becoming more popular.  To date, few studies have measured chronic changes 
in BTM’s in premenopausal women after exercise training.  Lohman and colleagues 
(72) studied the effects of an 18-month progressive resistance training program on lean 
muscle mass, aBMD, and serum OC in premenopausal women with normal menses not 
taking oral contraceptives.  The resistance training program consisted of 12 upper and 
lower body exercises designed to target major muscle groups and were performed at an 
intensity of 70% 1RM which was periodically reassessed and progressively increased to 
80% 1RM by the end of the study.  Blood samples and measurements of hip and spine 
aBMD were taken at baseline, 5, 12, and 18 months. Blood samples were drawn in the 
morning after an overnight fast during days 1-5 of the menstrual cycle. After 5 months 
of training, serum OC increased in the exercise group and remained elevated at 12 and 
18 months but did not change in the control group.  Furthermore, the exercise group 
also experienced increases in femoral trochanteric and lumbar spine aBMD compared to 
control. Increased bone formation markers were also reported by Shibata and colleagues 
(103) after a one-year walking combined with jumping intervention in premenopausal 
women.  43 premenopausal women were assigned to either a walking group or a 
walking combined with jumping group. Both groups were assigned to walk 10,000 steps 
per day with the walk-jump group assigned 10 maximal jumps per day in addition to the 
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10,000 steps.  Serum levels of bone formation markers Bone ALP and OC as well as the 
resorption marker NTX were measured at baseline and after one-year in both groups.  
Bone ALP was significantly elevated from baseline in both groups.  However, Bone 
ALP was higher in the walk-jump group compared to the walk-only group.  Serum 
levels of CTX were unaffected by exercise in either group.  The researchers concluded 
that adding exercises with higher ground reaction forces to a walking program had a 
more positive influence on bone metabolism than walking alone.  Adami and colleagues 
(4) conducted a two-part investigation to study the effects of physical activity on 
BTM’s.  First, 530 premenopausal women with normal menses not taking oral 
contraceptives were enrolled to take part in a cross-sectional investigation to determine 
the relationship between basal levels of BTM’s, self-reported physical activity levels, 
and aBMD of the femoral neck and lumbar spine.  All women had their blood drawn 
between 7:00 and 8:00 AM after an overnight fast which was analyzed for OC, PINP, 
and CTX.  The results of this observational study found that the BTM’s OC and PINP, 
but not CTX, were significantly associated with level of physical activity.  Additionally, 
spine and hip aBMD were related to physical activity levels, but only spine aBMD 
showed a statistically significant change.  With a subset of the women in the cross-
sectional study, the same researchers investigated the effects of a one-month moderate 
intensity weight-bearing aerobics program on BTM’s.  24 sedentary women in the 
exercise group and 18 age-matched controls participated in the intervention study. The 
exercise sessions were conducted 3-4 days per week lasting approximately 90 minutes 
and consisted of moderate intensity weight-bearing aerobic activities combined with 
spine flexion and extension strength exercises. After 4 weeks of exercise training, both 
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groups had their blood drawn and reanalyzed for levels of OC, PINP, and CTX.  A 
significant 25% increase in both OC and PINP occurred in the exercise group with no 
change in non-exercise controls.  The bone resorption marker CTX did not change in 
either group. From the evidence in both the intervention and cross-sectional study, the 
researchers concluded that increased physical activity is associated with a clear effect 
on bone formation markers and further explains the crucial role of physical activity 
toward bone health.  Recently, Lester and colleagues (68) conducted an investigation to 
determine the influence of different modes of exercise on BTM’s after training.  58 
premenopausal sedentary women were assigned to one of four groups: aerobic, 
resistance, combination, or non-exercise control. All three exercise groups met three 
days per week for 8 weeks. The aerobic group performed 30-60 minutes of either 
jogging or running at moderate to high intensities (70-85% HRmax). The resistance 
training group performed 6-8 exercises targeting the main muscle groups of the upper 
and lower body. Load and repetition was altered in a non-linear periodized fashion at 
each resistance training session over the 8-week period. The combined group performed 
both the resistance and aerobic regimens in a single session.  The resistance training 
portion was always performed first to maximize force production.  All participants had 
their blood drawn after a 12-hour fast at baseline, 4 weeks, and 8 weeks post-training to 
determine serum levels of the bone formation markers Bone ALP and OC as well as the 
resorption markers TRAP5b and CTX.  Dietary intake was recorded at baseline and was 
used to ensure that the same meal was consumed the day before the 4 and 8-week blood 
draws.  In order to minimize biological variability, both 4 and 8-week blood draws were 
taken 48 hours after exercise and during the same approximate phase of the menstrual 
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cycle. After 8 weeks of training, serum levels of BAP and OC were significantly 
increased in the resistance and combined training groups but not in the aerobic or non-
exercise control.  No training-related changes in serum CTX or TRAP5b were observed.  
The authors concluded that exercise programs with a resistance aspect are more 
effective at elevating serum markers of bone formation than programs consisting only 
of aerobic training.  
 With the current data available, it is difficult to definitively determine the effects 
of exercise training on BTM’s in premenopausal women. With regard to the studies 
discussed, the evidence presented suggests that exercise resulting in high impact ground 
reaction forces, moderate to high-intensity resistance training, or a combination of the 
two can favorably induce changes in the bone metabolic profile.  Whether these 
exercise-induced changes lead to future gains in bone mass is not known.  Because of 
the variability associated with BTM’s, it is absolutely necessary to standardize 
measurement protocols.  Menstrual status, menstrual phase, and oral contraceptive use 
all affect BTM’s and must be considered when designing studies to investigate the 
effects of exercise on BTM’s in premenopausal women.   
Exercise Interventions and BMD in Premenopausal Women 
 The sensitivity of the skeleton to mechanical loading through exercise is age-
dependent and it is widely accepted that the skeleton reaches its peak bone mass by the 
third decade (57).    Research has shown that bone in young premenopausal women 
responds differently to exercise compared to their postmenopausal counter-parts and 
this period in life may be the final opportunity to enhance bone mass before the 
menopause (7).  In humans, BMD is a widely used measure of bone strength and has 
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been estimated to account for approximately 60% of the variance in bone strength (57).  
Because low BMD is a risk factor for trauma-related fractures, determining an exercise 
prescription that enhances BMD and muscular strength in premenopausal women could 
potentially minimize bone loss and thus fracture risk in the later years.  A multitude of 
evidence from cross-sectional studies suggest that young women who participate in 
regular high-intensity resistance training (19, 46-48) or exercise that results in high-
impact forces such as gymnastics (17, 25, 93) have stronger bones than their sedentary 
age-matched counterparts.  However, longitudinal randomized controlled trials 
investigating the effects of different modes of exercise on bone mass in sedentary 
premenopausal women have reported only modest increases in aBMD (1-3 %), if any.  
 Resistance training as a means to increase bone mass in premenopausal women 
has been studied by several researchers. Snow-Harter and colleagues (105) conducted 
an 8-month study of the effects of resistance training on spine and hip aBMD in 
college-aged women.  The resistance training protocol consisted of 14 exercises 
designed to stress the major muscles of the upper and lower body and was completed 
three days per week.  Training intensity at the beginning of the study was 65% 1RM 
and was progressively increased to 85% 1RM by the end of the study.  In comparison to 
the non-exercise control group, the resistance training group significantly increased 
(1.2%) lumbar spine aBMD.  However, hip aBMD was unchanged.  Similar findings 
were reported by Lohman and colleagues (72) after an 18-month progressive resistance 
training program in premenopausal women.  Their training program, performed three 
days per week, consisted of 12 upper and lower body exercises designed to target major 
muscle groups.  The intensity commenced at 70% 1RM which was periodically 
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reassessed and progressively increased to 80% 1RM by the end of the study.  Hip and 
spine aBMD were taken at baseline, 5, 12, and 18 months.  The exercise group 
experienced a significant increase in lumbar spine (1.9%) and femoral trochanter (2.0%) 
aBMD compared to non-exercise controls. Others researchers investigating resistance 
training did not find significant changes in aBMD.  The studies by Sinaki et al. (104) 
and Gleeson et al. (39) both failed to show significant improvements in hip or spine 
aBMD in the exercise group compared to the control after resistance training exercise.  
This may be due to the prescribed intensity of exercise employed in their studies.  
Sinaki et al. reported their exercise as “non-strenuous” and back extension exercises 
were performed for 10 repetitions at 30% of 1-RM. Similarly, Gleeson et al. prescribed 
a “goal” intensity of 60% 1-RM for the eight exercises performed in their study.  Taken 
together, the results of these studies suggest that resistance training-induced bone mass 
gain may be intensity-dependent.  Thus, intensities that elicit greater bone-loading 
magnitudes are needed to augment bone accrual.  
 Exercises that result in increased ground reaction forces (GRF’s) have also been 
hypothesized as osteogenic.  Activities such as high-impact aerobics and jumping can 
result in GRF’s two to six times bodyweight (15, 23).  Bassey and colleagues (7) 
conducted a 6 month study investigating the effects of jump training on femoral neck, 
femoral trochacter, and lumbar spine aBMD.  55 premenopausal were randomly 
assigned to a jumping group or non-jumping control group.  The jumping program 
consisted of 50 maximal double-leg jumps (5 sets X 10 jumps) six days per week.  
GRF’s were sampled throughout the study with a force plate and determined to be, on 
average, three times body weight.  At the conclusion of the study, the jump group 
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significantly increased aBMD of the femoral trochanter (2.8%) and femoral neck, with 
no change in the lumbar spine.  Similar results have been reported by other researchers 
employing high GRF exercise interventions (28, 115).  Interestingly, these researchers 
also only found significant increases in hip aBMD but not lumbar spine, suggesting that 
high GRF activities may result in site-specific bone adaptations.  To test this hypothesis, 
Winters-Stone and colleagues (118) conducted a 12 month study investigating the site-
specific effects of jump training combined with either lower or upper body resistance 
exercise on spine and hip aBMD.  Women were assigned to one of three groups: Lower 
training, Lower + Upper training, or non-exercise control.  Both training groups were 
required to complete 9 sets of 10-12 jumps of varying height and direction as well as 9 
sets of 10-12 repetitions of squats and lunges.  The Lower + Upper training group 
performed 6 upper-body exercises for 3 sets each at an intensity of 8-12 RM.  The 
resistance was progressively increased throughout the training duration.  Both the 
Lower and Lower + Upper training groups significantly increased aBMD of the femoral 
trochanter (2.7% and 2.2%, respectively), but only the Lower + Upper group increased 
aBMD of the lumbar spine.  The results of this study suggest that bone adaptation to 
exercise training is site-specific.  Therefore, a combination of high-impact lower body 
exercises and upper-body resistance exercises would be optimal for augmenting bone 
accrual at multiple skeletal sites. 
 Recently, there has been some compelling evidence that high magnitude and/or 
high-impact loading may not be needed to improve or preserve bone mass.  Using a 
low-magnitude, high-frequency mechanical stimulus, Rubin and colleagues (98) 
reported significant increases in trabecular bone quantity and quality in the hind legs of 
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sheep exposed to 30 Hz vibration (approximately 5 microstrain) 20 minutes per day five 
days per week over 12 months.  These data in sheep suggest that low magnitude, high 
frequency loading delivers an osteogenic response to bone. Interestingly, muscle 
contractions have been shown to occur at frequencies up to 30 Hz while typical 
locomotor patterns such as walking deliver frequencies to the skeleton on the order of 1-
3 Hz (113).  To test the effects of high-frequency, low-magnitude loading on aBMD in 
humans, Beck and colleagues (9) recruited seven premenopausal women with known 
low aBMD to undergo 12 months of whole body vibration training at 30 Hz 
(approximately 5 microstrain).  Subjects were instructed to stand on the vibration 
platform every day for 10 minutes in the morning and at night.  aBMD of the hip, spine, 
and radius was assessed at baseline, six, and 12 months.  Following the year-long 
intervention, aBMD of the non-dominant proximal femur increased 2%.  No significant 
change was found at any other sites.  It must be noted that there are many 
methodological flaws inherent in this study.  The small number of subjects and a lack of 
a non-exercise control group undermine the beneficial results reported.  Because of the 
many short comings of this study, it is not possible to draw any definitive conclusions 
on the effects of this novel type of mechanical loading.  Nonetheless, if found to be 
beneficial in a randomized controlled trial, an intervention of this type could prove to be 
a safer option for frail individuals at risk for fracture.    
Blood Flow Restriction Training 
 In the last ten years, blood flow restriction (BFR) training has gained 
considerable attention in the United States.  This training method, also known as 
“KAATSU” training, has been popular in Japan for over 30 years (100).  BFR training 
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involves the use of an electronically monitored and controlled pneumatic air pressure 
cuff which is placed around the most proximal portion of an appendicular limb and 
inflated during exercise.  Most often, BFR cuffs have been used in conjunction with 
low-intensity (20-50% 1RM) resistance training.  The cuff pressure used varies, but is 
often above systolic brachial pressure (140-280 mmHg).  The cuffs are designed to 
occlude venous return as well as reduce arterial flow to the exercising limbs, thus 
causing venous pooling.  Two studies investigating cuff pressure and arterial blood flow 
found that a pressure of 160-200 mmHg around the proximal thigh reduced arterial flow 
30-60% (51, 108), but the degree of blood flow restriction is also dependent on the size 
of the underlying tissue (70, 102) .  
 The safety of BFR training has been a large concern with its use, as the idea of 
reducing blood flow to working muscle seems not only counter intuitive, but potentially 
harmful.  On the contrary, the use of tourniquets in the field of surgery is a widely 
accepted practice and the safety of its use has been well documented.    Studies show 
that tourniquets inflated at 350 mmHg are safe for use in duration of 90 minutes with no 
measurable muscle damage (99).  Additionally, a national survey in regards to safety 
and adverse events was sent to 105 facilities in Japan that regularly use BFR training 
and resulted in a response of approximately 13,000 people, ranging from under the age 
of 20 years to 70 years (79).  The number one adverse side effect reported was 
subcutaneous bruising (13.1%) at the sight of the cuff as well as numbness (1.3%).  
However, numbness usually subsided upon release of the cuff.   
 The novel finding that BFR combined with low-intensity (20-50% 1RM) 
resistance training increases muscle strength and muscle size comparable to traditional 
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high-intensity (75-85% 1RM) resistance training has been supported by a number of 
studies (3, 35, 85, 110).  Surprisingly, one investigation showed marked muscle 
hypertrophy measured by MRI in as little as six days (35).  These data are intriguing in 
that this training method might provide a safer alternative compared to high-intensity 
training for older individuals or those not able to lift heavy loads.  Several hypotheses 
exist as to how such low intensities combined with BFR result in hypertrophy, including 
increased muscle activation (110, 122),  increased secretion of anabolic hormones (76, 
86, 91, 108, 109), and more recently, through fluid shifts and cell swelling(69).  
However, the exact mechanism has yet to be elucidated. 
More recently, BFR has been used in combination with more functional exercise 
such as walking.  Abe and colleagues (1) first investigated the use of BFR walking in 
college-aged males.  BFR walk training was conducted two times per day, six days per 
week for three weeks in 18 men.  Restriction cuffs were worn bilaterally at the proximal 
thigh and commenced at 160 mmHg on day 1.  Pressure was increased 10 mmHg each 
day until a final pressure of 230 mmHg was reached (day 8) and maintained for the 
duration of the study.  Both subjects in the BFR walk group (n=9) and non-BFR walk 
group (n=9) walked at 50m/min for five two-minute bouts with one-minute rests in 
between.  Total time under restriction for the BFR group was 17 minutes for each 
session.  After 3 weeks of training, subjects in the BFR group significantly increased 
MRI-derived hamstring (7.6%) and quadriceps (5.7%) MCSA while no change occurred 
in the walk control group.  In addition, dynamic (8.3%) and isometric (10.5%) knee 
extension strength increased in the BFR group with no change in controls.  Similar 
findings have since been reported in older adults (2, 82).  Both of these studies utilized 
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BFR with low-intensity (45% heart rate reserve, 67 m/min) treadmill walking.  Unlike 
the previous study in young males, these studies used a 20-minute continuous bout with 
no intermittent recovery periods.  Again, both these studies reported significant 
increases in thigh MCSA and lower body strength compared to non-BFR walking 
control groups after 6 and 10 weeks of training, respectively. 
To date, no studies have been conducted on the long-term effects of BFR 
training on bone adaptations and only three studies have reported the effects of BFR on 
changes in BTMs.  Bemben et al. (11) conducted a repeated-measures crossover-design 
study on the acute effects of a single bout of low-intensity resistance training with and 
without BFR.  Nine college-aged men performed an initial warm-up set of 30 
repetitions at 20% 1RM.  Following warm up, 3 sets of 15 repetitions separated by 30 
seconds of rest were completed.  This protocol was followed for both leg extension and 
leg curl exercises in a BFR condition and non BFR condition.  Condition and starting 
exercise were randomly assigned with conditions being performed at least 48 hours 
apart.  BFR cuff pressure was set at 180 mmHg and maintained for the duration of both 
exercises.  Baseline blood samples were taken in the morning after an overnight fast 
followed by samples immediately and 30 minutes after exercise which were analyzed 
for Bone ALP and NTx.  No change in serum levels of Bone ALP were reported at any 
time point or condition.  However, NTx significantly decreased 30 minutes post 
exercise in the BFR condition with no change in the control condition.  The researchers 
concluded that the decrease in bone resorption in the BFR condition might be due to the 
hypoxic and/or acidic environment caused by the restriction.  Significant alterations in 
BTM’s were also observed by Karabulut and colleagues (53) after six weeks of low-
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intensity resistance training with BFR.  37 older male subjects were assigned to one of 
three groups: high-intensity (80% 1RM) resistance training, low-intensity (20% 1RM) 
resistance training with BFR, and non-exercise control.  Both exercise groups 
performed the same upper and lower body exercises, but lower body ( leg press and 
knee extensions) were performed for 3 sets by 8 reps at 80% 1RM for high-intensity 
group and 1 set for 30 reps, followed by 2 more sets at 15 reps at 20% 1RM for the BFR 
group. Cuff pressure was initiated at 160 mmHg at the onset of training and increased 
progressively throughout the intervention.  Blood samples were obtained at baseline and 
at completion of the study in the morning following an overnight fast.  Following the 
intervention, Bone ALP significantly increased by 20% in both exercise groups 
compared to the non-exercise control. CTx was unchanged in any group.  The 
researchers concluded that low-intensity resistance training with BFR may be as 
effective as traditional high-intensity resistance training for improving bone health in 
older adults.   
 Currently, only one study on the effects of walking with BFR on bone markers 
has been published.  Using the same protocol and participant population as the 
previously discussed walking study by Abe’s group, Beekley and colleagues (10) 
measured the serum bone formation marker Bone ALP at baseline and three weeks after 
walk training with or without BFR.  Blood samples were obtained after an overnight 
fast at approximately the same time in the morning with the post-training sample three 
days after the last exercise session.  Following three weeks of training, a significant 
increase (10.8%) in Bone ALP was observed in the BFR walk group with no change in 
the control walk group.   
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Summary 
From the literature available, it seems that high-impact weight-bearing exercises 
resulting in large GRF’s and high-intensity resistance training provide premenopausal 
women with the most potential to increase bone mass prior to the menopause. However, 
these types of exercise may not be appropriate for women with already low bone mass 
at increased risk for fracture.  Walking with BFR is known to result in increased thigh 
MCSA and lower-body strength in young men and older adults (1, 2) and has also been 
shown to increase levels of Bone ALP in college-aged men after three weeks (10).  
What is not known, however, is what effects walking with BFR have on serum markers 
of bone metabolism in young premenopausal women. 
 
 
 
 
 
 
 
 
 
 
 
 
 
39 
 
CHAPTER III 
METHODOLOGY 
The purpose of this study was to investigate the effects of 12 weeks of walking 
with and without blood flow restriction on metabolic markers of bone turnover in 
college-aged women.  A secondary purpose of the study was to assess changes in thigh 
and calf MCSA, muscular strength, aerobic capacity, and cortical and trabecular bone 
characteristics of the tibia following the 12-week intervention. 
Subjects 
 Seventy-six young women from the University of Oklahoma and city of 
Norman, OK and its surrounding area initially responded with interest to the study via 
contact from flyer posted in public or university-approved areas, direct recruitment from 
classrooms in the Department of Health and Exercise Science, and University mass 
email (Appendix A).  Of the 76 respondents, 42 met the initial screening criteria 
checklist (Appendix B) and were scheduled for their first visit to the Bone Density 
Research Laboratory to fill out an Informed Consent (Appendix C) and questionnaires 
used to further determine study eligibility (Appendix D). Two additional subjects were 
excluded after the initial visit based on their answers to the health history questionnaire. 
Therefore, 40 women between the ages of 18-30 years satisfying the inclusion/exclusion 
criteria below were randomly assigned to one of the three study groups (WALK, BFR, 
and CON) and were scheduled for baseline testing.  All methods and procedures were 
approved by the University of Oklahoma Health Sciences Center Institutional Review 
Board (IRB No. 16049) (Appendix E). Subject inclusion and exclusion criteria were as 
follows: 
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Inclusion Criteria 
1. Women 18-30 years old. 
2. Combined oral contraceptive use  > 1 month. 
3. Free of chronic back or joint problems, cardiovascular disease, non-smokers, not 
pregnant, not taking antihypertensive drugs or any medication known to affect bone 
metabolism. 
4. Not currently participating in exercise such as resistance training, circuit training, 
and/or moderate to high-intensity aerobic more than two days per week for the last 
3 months.  
Exclusion Criteria 
1. Outside the 18-30 year age range. 
2. Not taking combination oral contraceptives. 
3. The use of any prescription medications other than combined oral 
contraceptives. 
4. Weighing more than 300 lbs or over 74 inches (DXA machine requirement). 
5. Structured exercise > 3 days per week over the last 3 months. 
6. Not able to perform the physical requirements of the study. 
7. Pregnant women or women who think they may be pregnant. 
8. Regular use of tobacco products (cigarettes, cigars, chew/snuff etc.). 
9. Have a history of cardiovascular disease or thromboembolic disease. 
10. Is a current student of Dr. Debra Bemben. 
11. Is identified as a moderate- to-high risk individual as described by the American 
College of Sports Medicine: 
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a. At least two of the following: Father or brother, or mother or sister that 
has had a sudden death before 55 or 65 years of age, respectively; Is a 
current cigarette smoker or has quit smoking within the previous 6 
months; Is on hypertensive medication or has a confirmed systolic or 
diastolic blood pressure ≥ 140 or 90 mmHg, respectively; Is on lipid 
lowering medication or has a total cholesterol level ≥200 mg/dL; Has a 
confirmed fasting blood glucose of ≥100 mg/dL; is clinically obese. 
12. Having more than one risk factor for Thromboembolisms. 
a. Classified as Obese based on a Body Mass Index of  > 30; 
b. Diagnosed Crohn’s or Inflammatory Bowel Disease; 
c. Past fracture of a hip, pelvis, or femur; 
d. Major Surgery within the last 6 months; 
e. Varicose veins are present; 
f. Family history of Deep Vein Thrombosis or Pulmonary Embolism. 
 
Research Design 
 The current study was a randomized, controlled trial with repeated-measures 
design conducted at the University of Oklahoma's Bone Density Research and 
Neuromuscular laboratories housed in the Department of Health and Exercise Science. 
The duration of the study was 14 weeks, including one week for pre-testing, 12 weeks 
of training (4 times per week for a total of 48 sessions), and one week for post-testing. 
Upon the initial visit, subjects were informed about the study details and given ample 
time to ask questions.  Subjects then filled out several questionnaires including an 
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informed consent form and other questionnaires used to determine study eligibility. 
Once determined eligible, 40 women aged 18-30 years from the University of 
Oklahoma and city of Norman, OK and its surrounding area were randomly assigned 
using a random number generator computer program to one of three groups: low-
intensity treadmill walk group with blood flow restriction (BFR, n=14), low-intensity 
treadmill walk control group (WALK, n=14), or a non-exercise control group (CON, 
n=12) and scheduled for their next three testing visits.  On the first testing day, subjects 
arrived at the university’s health clinic to have their blood sampled after an overnight 
fast between 8:00 and 10:00am.  After blood sampling, subjects came to the Bone 
Density Research laboratory to undergo a urine pregnancy test to ensure they were not 
pregnant prior to undergoing DXA and pQCT bone scans. After scans were completed, 
subjects were taken to the Neuromuscular laboratory and familiarized with the strength 
testing procedures and equipment.  Day two of testing consisted of 1RM strength testing 
for knee extension and flexion and MVCs of the knee extensor/flexors at knee joint 
angles of 30 and 60 degrees.  The third day of testing included a maximal graded 
exercise treadmill test for determination of walking speed used during the training 
intervention as well as VO2peak.  All measures previously described were performed at 
baseline and post-training in the same testing order.  However, the post-training blood 
samples were obtained in the Bone Density Research laboratory by a nurse rather than 
the university’s health center to accommodate a large number of subjects within a 
restricted time frame. 
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Exercise Protocol 
 Subjects in the BFR and WALK groups walked on a motor-driven treadmill four 
times per week for 12 weeks (48 total sessions) at a speed associated with 45% VO2peak, 
determined during their baseline maximal treadmill test.  The treadmill speed was 
maintained throughout the duration of the study.  However, the incline of the treadmill 
was increased by 1% at the start of week five and again at week nine.  During the first 
week, each exercise session was 10 minutes in duration. At the start of week two, 
session duration was increased to 15 minutes and again increased to 20 minutes at the 
start of week three and maintained until the end of the study. Before each exercise 
session, the BFR group was fitted with pneumatic elastic pressure cuffs (5cm in width) 
(Kaatsu-Mini, Tokyo, Japan) around the most proximal portion of the thighs.  Subjects 
were seated in a chair and the cuffs were applied with an initial sitting pressure of 50 
mmHg.  The cuffs were then inflated to 120 mmHg, held for 30 seconds and then 
deflated. This process was repeated by adding 10 mmHg pressure until the target 
exercise pressure was attained.  Initial exercise pressure was set at 140 mmHg for 
weeks one through four, increased to 160 mmHg during weeks five through eight, and 
increased to 180 mmHg for the final four weeks.  This pressure progression was 
tolerated well by all subjects with the exception of one, who visually had the smallest 
thigh circumference among the BFR group and was therefore maintained at 160 mmHg 
for the final four weeks of the intervention. This pressure stimulus was chosen based on 
pilot work performed in our laboratory which was well tolerated during four weeks of 
BFR walking. The cuff pressure was maintained by an electronic air pressure system 
throughout the exercise session and was released immediately on completion of the 
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session. Heart rate and rate of perceived exertion were monitored and recorded every 
two minutes during each exercise session.  A table illustrating the exercise protocol is 
provided in the appendices (Appendix F).  The CON group was asked not to change 
their current physical activity levels for the duration of the training period and only 
participated in the baseline and post-training testing sessions. 
Questionnaires 
 After consent had been given, subjects completed a health history and status 
questionnaire, Physical Activity Readiness Questionnaire (PAR-Q), and menstrual 
history questionnaire.  All three questionnaires were used to determine any additional 
exclusion criteria including menstrual status and oral contraceptive use. In addition, a 3-
day dietary food log was completed for Thursday-Saturday of the first week of exercise 
and again during the last week of exercise (Appendix D).  Food logs were analyzed 
using ESHA Food Processor version 10.8 (ESHA Research, INC., Salem, OR) for 
average daily caloric intake, protein intake, calcium intake, and vitamin D intake.  
Body Composition/Bone Mineral Density 
1. Dual Energy X-ray Absorptiometry (DXA) 
All participants had DXA (GE Medical Systems, Lunar Prodigy encore software 
version 10.50.086, Madison, WI) scans to assess areal bone mineral density (aBMD) of 
the total body, dual proximal femur (femoral neck, trochanter, and total hip) and AP 
spine (L2-L4). A total body scan was performed to obtain bone free lean leg mass 
(LegLM), total bone free lean body mass (BFLBM), and percent body fat (%BF). 
Quality assurance testing (QA) was performed each day that scans were performed to 
ensure that the DXA was operating properly.  The first step of QA for the DXA was a 
45 
 
scanning calibration block of known density, and a series of mechanical functioning 
tests, which the software ran automatically.  All individual tests had to pass for the 
overall QA to pass.  The second step of the QA testing was scanning a phantom spine 
block of known density.  The L2-L4 density had to fall within the predetermined range 
to pass.  
 For the total body scan, the participants laid supine on the DXA table with arms 
close to the sides.  Velcro straps were placed around their legs to ensure that the legs 
remained still and relaxed.  For the AP lumbar spine scan, the legs were lifted and set 
on a foam block, such that the there was a bend in the knee, and the angle created by the 
thighs and the scanning bed was 45-90 degrees.  The technician ensured that the iliac 
crests were even, and the lumbar spine was resting flat on the scanner bed.  The scanner 
arm was centered with the torso as marked by the participant’s navel, and placed 
approximately 5 cm below the navel to ensure that the iliac crests as well as the T12 
vertebra were visible on the scan.  The subjects’ arms were crossed over the chest and 
then moved to directly over the chin and the scan was started.  Scan speeds for the total 
body and lumbar spine were determined by the measured thickness of the subject at the 
naval (Thick = >25 cm; Standard = 13 – 25 cm; and Thin  = < 13 cm). The dual femur 
scans were performed using the standard setting. Participants’ legs were internally 
rotated and secured in place to ensure proper exposure of the femoral neck and the 
femur was positioned parallel to the scanning boundary.  The scan began just below the 
pubic symphysis, centered on the thigh being scanned, and finished 3 to 4 sweeps above 
the head of the femur. 
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All scans were performed by a trained technician with day to day technician 
precision ranging from 0.38 – 1.1% for the sites of interest.  
2. Peripheral Quantitative Computed Tomography (pQCT) 
All participants had their total, trabecular and cortical volumetric bone mineral 
density (vBMD) and volumetric bone characteristics at 4%, 38% and 66% of the limb 
length proximal to the boney endplate of the right tibia, and 50% of the right femur 
determined by a peripheral quantitative computed tomography scanner, XCT 3000 with 
software version 6.00 (Stratec Medizintechnik GmbH, Pforzheim, Germany) by a single 
trained pQCT technician.  Quality assurance test scans were completed each testing day, 
where a phantom cone of known densities underwent a scout view scan, and a series of 
4 scans that the software ran automatically.  The densities had to be within 99% 
accuracy in order for the quality assurance test to pass. Scans were acquired with a 
voxel size of 0.4 mm, slice thickness of 2.2 mm, and a scan speed of 20 mm/sec.  
Analysis of bone slices were performed using custom macros using the XCT software. 
Analysis thresholds were chosen to separate cortical bone from trabecular bone, and 
bone from fat and muscle. Thresholds used for the bone analyses at the 4% site were 
Contmode 3, Peelmode 4, Threshold1 169, Threshold 2 650, Cortmode 2, Threshcrt1 
480, Threshcrt 0.  Thresholds used for the tibia 38% and 66% and femur 50% sites were 
Contmode 1, Peelmode 2, Threshold1 710, Threshold2 710, Cortmode 2, and Threshcrt 
710.  An additional line of analysis with a threshold of 480 mg/cm3was used for both 
the 38% and 66% tibia sites.  This threshold allows subcortical bone to be included in 
the analysis for the determination of stress-strain index (SSI), a measure of bone 
torsional and bending strength.  Muscle cross-sectional area (MCSA) of the tibia 66% 
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and femur 50% sites were determined by drawing a region of interest around the total 
CSA scan and analyzed for MCSA using two lines of threshold driven analyses along 
with the median smoothing filter F01F06U01. The first analysis separates fat + marrow 
from the total CSA leaving total bone + muscle area. In the second analysis, total bone 
area is determined and subtracted from the total bone + muscle area, effectively leaving 
MCSA only.  In the Bone Density Research Laboratory, the in vivo precision for 
measurement of total vBMD, BMC and bone area is 0.3% - 1.9%.  In vivo precision 
ranges for measuring vBMD, BMC and area variables for the trabecular and cortical 
compartments are 1.1% - 5% and 0.5% - 1.7%, respectively.  In vivo precision for the 
femur MCSA measurement is 0.9%. 
Strength Testing 
1. One Repetition Maximum (1RM) 
1RM testing was performed at baseline and post-training to determine dynamic 
muscular strength of the knee flexors and extensors using knee flexion and knee 
extension weight machines (Cybex International, Inc., Medway, MA.).  Participants 
performed a 5-minute warm up on a stationary cycle ergometer followed by a warm up 
set of 8-10 repetitions using 50% of their predicted 1RM.  After a one-minute rest, the 
load was increased and subjects performed a set of 3-5 repetitions. Following a two-
minute rest, the load was increased and subjects performed their first maximal attempt. 
After each successful attempt through the full range of motion, the load was increased 
until a failed attempt occurred. Two-minute rest periods were given between each 
maximal attempt and 1RMs were achieved between 3-5 attempts.  
2. Maximal Voluntary Contraction (MVC) 
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MVCs of the knee flexors and extensors were performed at baseline and post-
training on an isokinetic dynamometer (Biodex Medical Systems, Shirley, NY) to 
determine maximal isometric strength.  Knee flexion and extension were performed at 
joint angles of 30 and 60 degrees, as measured by a goniometer. Participants performed 
one repetition for each muscle group at 50% of maximal perceived effort. After this 
initial warm-up, participants performed three repetitions at maximal effort for the knee 
flexor and extensor muscles. One-minute rest periods were provided between warm-up 
repetitions and between maximal trials. The highest torque output measured for each of 
the three maximal attempts was considered the MVC for that particular test. 
Aerobic Capacity 
Participants underwent a maximal graded exercise treadmill test at baseline and 
post-training to determine their aerobic capacity.  A mouthpiece attached to a head 
harness was secured to the subject and nose clips were placed on the subject’s nose to 
allow only mouth breathing.  Once the subject was ready to begin the test protocol, the 
subject was asked to straddle the treadmill with both legs while the treadmill was turned 
on to an initial warm up speed of 2.0 mph at a 0% grade.  The subject carefully stepped 
onto the treadmill and walked at this initial warm up workload for 90 seconds.  The 
treadmill speed was then increased to 3.0 mph and held there for an additional 90 
seconds. The treadmill speed was then increased to 3.5 and 4.0 mph and held at each 
speed for 90 seconds. This warm up procedure was used to ensure the subject had 
adequate warm up time and also used to prescribe the exercise intensity for the training 
sessions. After warm up, the speed was increased to 5.5 mph and held constant for the 
remainder of the test.  Every two minutes thereafter, the treadmill grade was increased 
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2%. The subject was encouraged to exercise to their volitional fatigue unless the subject 
experienced clinical signs to terminate the exercise test as stated by the ACSM’s 
Guidelines for Exercise Testing and Prescription (i.e., angina, dyspnea, dizziness, a 
decline in systolic blood pressure, lightheadedness, confusion, ataxia, cyanosis, nausea, 
chronotropic impairment, failure of the monitoring system, or other signs or symptoms 
for terminating the test).  VO2peak was determined using the TrueOne 2400 metabolic 
measurement system (Parvo Medics, Sandy, UT).  
Blood Sampling 
 Resting blood samples (approximately 7 ml) were collected by a nurse from the 
subject’s antecubital vein via venipuncture between the hours of 8:00 and 10:00 am 
following an overnight fast at baseline and post-training.  The post-training blood 
sample was collected 48-72 hours following the last exercise session.  Blood samples 
were allowed to clot at room temperature for 30 minutes.  Each sample was separated 
by centrifugation (IEC Centra CL3, Thermo Electron Corporation, Milford, MA) and 
serum transferred to eight polystyrene microtubes labeled by subject ID and date and 
stored in a -80°C freezer until assay analyses.  Serum samples were only thawed one 
time prior to analysis.  
Bone Turnover Marker Assays  
1. Bone-specific Alkaline Phosphatase (Bone ALP):  
Serum samples were measured in duplicate using the MicroVue Bone ALP EIA 
Kit (Quidel Corporation, San Diego, CA, U.S.A.).  The EIA kit utilizes a monoclonal 
anti-BAP antibody.  The catalytic activity of the captured enzyme is used to measure 
Bone ALP activity in serum. Enzyme activity is determined spectrophotometrically and 
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Bone ALP concentrations are then calculated from a calibration curve fit with a 
quadratic equation. The Bone ALP assay was performed precisely to manufacturer’s 
specifications. Values are expressed as Units per Liter (U/L), with each unit 
representing one mole of p-nitrophenyl phosphate (pNPP) hydrolyzed per minute at 
25°C.  Intra-assay and inter-assay percent coefficient of variation were 6.7-9.5%, and 
4.7%, respectively. 
2. Tartrate-resistant acid phosphatase isoform 5b (TRAP5b) 
Serum samples were analyzed in duplicate for TRAP5b using the MicroVue 
TRAP5b ELISA kit (Quidel Corporation, San Diego, CA).  Enzyme activity is 
determined spectrophotometrically and the TRAP5b concentrations are then calculated 
from a calibration curve fit with a quadratic equation. The assay kit was performed 
precisely to manufacturer’s specifications and guidelines.  Units are reported in Units 
per Liter (U/L).   Intra-assay and inter-assay percent coefficient of variation were 0.7-
5.5% and 3.7%, respectively.   
Data Analyses 
 Data are reported as mean ± SE for all dependent variables.  Statistical analyses 
were performed using PASW for Windows version 18.0 (PASW, Inc., Chicago, IL).  
Group differences in baseline values for the dependent variables were determined using 
one-way analysis of variance (ANOVA).  If significant group differences existed at 
baseline, a one-way analysis of covariance (ANCOVA) was used to determine group 
differences in the post variables using the baseline variable as the covariate.  In the case 
that no group differences existed at baseline, a 3x2 mixed-factorial ANOVA with 
repeated measures ([group (CON vs. WALK vs. BFR) x time (pre vs. post)] was used to 
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analyze changes between groups and across time for each dependent variable.  If a 
significant group x time interaction was detected, follow-up analyses included paired-
samples t-tests and one-way ANOVAs.  Percent change from baseline was calculated 
for the main dependent variables using the following equation: %∆ = [(post – pre) / pre] 
X 100.  Normality of all percent change from baseline dependent variables was 
determined using a Kolmogorov-Smirnov procedure.  Based on this analysis, eight of 
the percent change variables were not normally distributed.  Therefore, Kruskal-Wallis 
one-way ANOVAs with pair-wise comparisons were used to determine group 
differences in these variables.  For all other percent change variables, a one-way 
ANOVA was used to determine group differences.   
 Pearson Product Moment Correlation Coefficients were run to determine 
relationships between the bone turnover markers and baseline aBMD and dietary 
variables and between baseline dietary variables and the tibia bone variables.  
Significant correlates were then used as covariates for the bone turnover markers and 
tibia bone variables in the analysis described above. The level of significance was set at 
p ≤ 0.05.     
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CHAPTER IV 
RESULTS AND DISCUSSION 
The purpose of this study was to investigate the effects of 12 weeks of walking 
with and without blood flow restriction on metabolic markers of bone turnover in 
college-aged women.  A secondary purpose of the study was to assess changes in thigh 
and calf MCSA, muscular strength, aerobic capacity, and cortical and trabecular bone 
characteristics of the tibia following the 12-week intervention. 
Subject Characteristics 
 A total of 40 subjects originally qualified for the study and were randomized 
into one of the three study groups: low-intensity treadmill walk group with blood flow 
restriction (BFR, n=14), low-intensity treadmill walk control (WALK, n=14), or a non-
exercise control group (CON, n=12).  However, nine subjects withdrew or were 
withdrawn from the study for the following reasons: five due to time commitments, one 
stopped the use of combined oral contraceptives, one lost employment and relocated to 
another city, one became ill with mononucleosis, and one was lost to post-testing 
follow-up.  Therefore, 31 subjects (BFR, n=11; WALK, n=10, CON, n=10) completed 
the entire study protocol with a 100% attendance rate for the 48 exercise sessions.   
 Baseline physical characteristics and average daily nutrient intake variables 
estimated from a 3-day food log are presented in Table 1.  No significant group 
differences existed at baseline.   
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Areal Bone Mineral Density 
 Group values for aBMD of the total body (TB), hip, and spine at baseline and 
post-training are presented in Table 2.  Baseline aBMD of the AP lumbar spine (L2-L4) 
was used to describe bone health status of each group using their associated Z-scores for 
age, gender, and ethnicity using the ISCD classification for premenopausal females (6).  
Under this classification, any female with a Z-score of < -2.0 is considered to have low 
aBMD for the spine.  Only one subject in the WALK group met the ISCD criterion for 
low aBMD for the spine.  All other subjects had a spine Z-score > -2.0.  Significant 
group differences at baseline were found for TB aBMD and femoral neck aBMD.  One 
way ANCOVA adjusting for baseline differences did not detect significant group 
differences in post-training TB aBMD or femoral neck aBMD.  Similarly, no main 
effects for time or group x time interactions were found for total hip or L2-L4 aBMD.  
However, mixed factorial ANOVA with repeated measures detected a significant 
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(p<0.01) group x time interaction for trochanter aBMD.  Follow up analyses revealed 
that the CON group significantly (p<0.01) increased trochanter aBMD from baseline.   
Table 2. aBMD of the Total Body, Hip, and Spine Before and After Training. 
Group
BFR (n=11) WALK (n=10) CON (n=10)
Variable Pre Post Pre Post Pre Post
 TB aBMD 1.064 ± 0.018 1.071 ± 0.021 1.117 ± 0.024 1.115 ± 0.023 1.163 ± 0.028 1.165 ± 0.027
 Fem Neck aBMD 0.990 ± 0.027 0.985 ± 0.025 1.017 ± 0.033 1.022 ± 0.035 1.095 ± 0.024 1.098 ± 0.025
 Troch aBMD † 0.771 ± 0.020 0.772 ± 0.020 0.807 ± 0.044 0.805 ± 0.045 0.852 ± 0.020 0.863 ± 0.020*
 Tot Hip aBMD 0.983 ± 0.022 0.983 ± 0.022 1.018 ± 0.042 1.018 ± 0.044 1.087 ± 0.024 1.094 ± 0.024
 L2-L4 aBMD 1.185 ± 0.036 1.182 ± 0.035 1.181 ± 0.034 1.185 ± 0.031 1.292 ± 0.045 1.286 ± 0.049
Values are mean ± SE. aBMD: areal Bone Mineral Density, TB: Total Body, Fem: Femoral, Troch: Trochanter, Tot: Total,  
 BFR: Blood Flow Restriction, WALK: Walking only, CON: Non-exercise Control. aBMD variables expressed in g/cm2.
† Significant group x time interaction, p=0.008. * Significant increase from Pre, p=0.009.
  
Serum Markers of Bone Turnover 
 Resting serum concentrations of Bone ALP and TRAP5b at baseline and post-
training for each group are presented in Table 3.  There were no significant group 
differences at baseline for either bone marker.  A significant (p=0.002) main effect for 
time and significant (p=0.02) group x time interaction was detected for Bone ALP.  
Follow up analyses revealed significant reductions in serum Bone ALP concentrations 
in both BFR (p=0.02) and CON (p=0.02) groups after the 12-week intervention. No 
significant main effects for time or group x time interactions existed for serum 
TRAP5b, and this remained true after adjusting for TB aBMD using ANCOVA.  No 
significant main effects for time or group x time interactions existed for Bone ALP to 
TRAP5b ratio.   Reference serum values provided by the ELISA kit manufacturer for 
premenopausal women 25-44 years of age are 11.6-29.6 U/L and 1.5-4.3 U/L for Bone 
ALP and TRAP5b, respectively.  Several participants had baseline Bone ALP values 
outside the normal reference range.  Specifically, 30% (3/10), 55% (6/11), and 70% 
(7/10) of participants in the WALK, BFR, and CON groups, respectively, had baseline 
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values higher than the reference range.  This is not unexpected, as the women in this 
study are younger than the established reference age range.  It has been previously 
shown that women below 25 years of age have higher rates of bone turnover, likely due 
to continued accretion of bone mass (40).  All participants were within the normal 
reference range for serum concentrations of TRAP5b.    
Table 3. Serum  Markers of Bone Turnover Before and After Training.
Group
BFR (n=11) WALK (n=10) CON (n=10)
Variable Pre Post Pre Post Pre      Post
Bone ALP (U/L)† 29.6 ± 2.8  27.6 ± 2.4* 28.0 ± 2.4 28.4 ± 2.2 34.7 ± 3.4  31.1 ± 3.2* 
TRAP5b (U/L)  2.8 ± 0.3  2.7 ± 0.4   2.6 ± 0.3     2.6 ± 0.3     2.5 ± 0.1    2.5 ± 0.2
Ratio 11.0 ± 1.1 11.2 ± 1.5 11.5 ± 1.3 11.5 ± 0.9 14.2 ± 0.3  12.8 ± 1.4
Values are mean ± SE. Bone ALP: Bone-specific Alkaline Phosphatase, TRAP5b: Tartrate-Resistant Acid   
Phosphatase Isoform 5b, BFR: Blood Flow Restriction with walking, WALK: Walking only, CON: Non-exercise
Control. † p=0.02, significant group x time interaction , * p=0.02, significant decrease from Pre
  
 Percent changes from baseline in serum concentrations of Bone ALP, TRAP5b, 
and the ratio of Bone ALP to TRAP5b are shown in Figure 1.  One-way ANOVA 
detected significant group differences in percent changes of serum Bone ALP 
concentrations from baseline (p=0.005).  Compared to WALK (1.9%), the CON (-9.7%) 
group experienced a significant (p=0.004) reduction from baseline in serum Bone ALP 
concentration.  No significant group differences in percent change from baseline were 
detected for serum TRAP5b or ratio of Bone ALP to TRAP5b.  
 The bone marker responses were not correlated with percent changes in body 
weight or total caloric intake.  However, baseline vitamin D intake was positively 
related to the percent change in TRAP5b (r=0.37, p=0.04). 
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  Body Composition  
 Baseline and post-training measurements of body composition for each group 
are presented in Table 4.  There were no significant group differences at baseline for 
any of the variables.  A significant group x time interaction was detected for body 
weight (p=0.034).  However, follow-up analyses did not detect any significant post-
training group differences or within-group differences over time.  Figure 2 depicts the 
change in body weight for each group over the 12 week intervention.  Percent change in 
body weight was significantly different between the two exercise groups (p<0.05) as the 
WALK had a 2.4 ± 1.3% increase in weight compared to a -0.8 ± 0.6% decrease in the 
BFR group.  The CON group remained stable with a -0.07 ± 0.7% change in body 
weight.  A significant main effect for time (p=0.02) and significant group x time 
interaction (p=0.002) was detected for MCSA at the tibia 66% site. Follow-up analyses 
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revealed that tibia 66% MCSA significantly increased from baseline in both BFR 
(p<0.05) and WALK (p=0.002) groups.  No significant main effects for time or 
significant group x time interactions existed for percent body fat (% BF), bone free lean 
body mass (BFLBM), bone free lean leg mass (LegLM), or MCSA at the femur 50% 
site.          
Table 4. Measures of Body Composition Before and After Training. 
Group
Variable BFR (n=11) WALK (n=10) CON (n=10)
Body Weight (kg) † Pre       58.4 ± 2.2       64.0 ± 2.4       61.9 ± 2.2
Post       58.0 ± 2.2       65.4 ± 2.4       61.9 ± 2.4
% Body Fat Pre       29.5 ± 1.7       33.7 ± 2.7       32.7 ± 1.8 
Post       29.2 ± 1.5       34.8 ± 2.3       33.6 ± 1.9 
BFLBM (kg) Pre       36.8 ± 1.0       38.3 ± 1.0       37.8 ± 1.2 
Post       37.1 ± 1.1       38.8 ± 1.1       37.3 ± 1.2 
Leg LM (kg) Pre       12.9 ± 0.4       13.3 ± 0.4       13.2 ± 0.5 
Post       12.9 ± 0.4       13.7 ± 0.4       12.8 ± 0.5 
Tib66% MCSA (mm2) † Pre   6134.5 ± 169.6   6333.4 ± 143.1   6309.3 ± 151.8
Post   6241.4 ± 158.1*   6560.8 ± 165.6*   6216.8 ± 153.3
Fem50% MCSA (mm2) Pre 10733.4 ± 418.8 10930.1 ± 364.5 10982.3 ± 364.5 
Post 10676.9 ± 359.3 10929.3 ± 395.0 10686.7 ± 409.4 
Values are mean ± SE. BFLBM: Bone Free Lean Body Mass, FM: Fat Mass, LM: Lean Mass,  
MCSA: Muscle Cross-Sectional Area, Tib66%: Tibia 66% site, Fem50%: Femur 50% site. 
BFR: Blood Flow Restriction, WALK: Walking only, CON: Non-exercise Control.
† Significant group x time interaction. *Significant increase from Pre.    
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 Percent changes from baseline for body composition variables are shown in 
Figure 3.  Significant group differences in percent changes from baseline were found for 
Tib66% MCSA (p=0.002).  Compared to CON, WALK (p=0.002) and BFR (p=0.042) 
groups experienced a significant percent increase (CON: -1.5%, WALK: 3.6%, BFR: 
1.8%) in Tib66% MCSA from baseline.  No significant group differences in percent 
changes from baseline were detected for any other body composition variables.  
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Muscle Strength 
 The 1RM and MVC muscle strength for the knee flexors and extensors at 
baseline and post-training are shown in Table 5. No significant group differences in 
strength existed at baseline. Repeated-measures ANOVA detected a significant main 
effect for time for MVC strength of the knee extensors at joint angles of 30 degrees 
(p=0.02) and 60 degrees (p=0.004), with no differences between groups.  No significant 
differences for main effects or group x time interactions existed for MVC strength of 
the knee flexors at either joint angle.  A significant group x time interaction was 
detected for 1RM knee extension strength (p=0.014).  Follow-up analyses revealed a 
significant (p=0.026) increase in 1RM knee extension strength over time for the BFR 
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group (Figure 4).  No significant main effects or group x time interactions existed for 
1RM knee flexion strength.             
Table 5. Muscle Strength Before and After Training. 
Group
Variable BFR (n=11) WALK (n=10) CON (n=10)
MVCs:
  Knee Ext 30° (N-m) + Pre 116.3 ± 5.8   118.5 ± 9.0   123.1 ± 7.8 
Post 127.7 ± 7.4   128.2 ± 9.0   123.0 ± 9.0 
  Knee Flx 30° (N-m) Pre   74.7 ± 4.1     84.9 ± 4.8     80.0 ± 5.5 
Post   78.8 ± 4.3     85.8 ± 2.8     80.6 ± 5.9 
  Knee Ext 60° (N-m)+ Pre 171.9 ± 9.9   174.8 ± 11.5   175.0 ± 9.5 
Post 187.3 ± 10.3   184.3 ± 11.1   180.2 ± 9.9 
  Knee Flx 60° (N-m) Pre   73.3 ± 4.0     80.8 ± 4.0     75.3 ± 4.5 
Post   76.3 ± 4.0     77.4 ± 3.2     76.6 ± 5.0 
1RM:
  Knee Extension (kg)† Pre  57.3 ± 2.6     64.2 ± 2.4     61.4 ± 3.4
Post  60.2 ± 3.4*     65.7 ± 2.4     60.0 ± 3.0 
  Knee Flexion (kg) Pre  58.1 ± 2.2     61.4 ± 2.4     58.0 ± 2.9 
Post  60.7 ± 2.0     61.7 ± 2.5     57.7 ± 3.0 
Values are mean ± SE. MVC: Maximal Voluntary Contraction, Ext: Extension, Flx: Flexion, 1RM:  
 1-Repetition Maximum, BFR: Blood Flow Restriction, WALK: Walking only, CON: Non-exercise Control.
† Significant group x time interaction. +Significant time effect.*Significant increase from Pre  
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 Percent changes in knee extension and flexion 1RM muscle strength from 
baseline are shown in Figure 5.  One-way ANOVA failed to detect significant group 
differences in percent changes from baseline in any of the MVC strength variables. 
However, a significant (p=0.034) group difference in percent change from baseline was 
detected for 1RM knee extension strength using the Kruskal-Wallis analysis.  Follow-up 
analyses with pairwise comparisons revealed that BFR and CON groups were 
significantly (p=0.028) different from each other.  No group differences were observed 
for percent change from baseline in 1RM knee flexion strength.   
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Aerobic Capacity  
 VO2peak at baseline and post-training for each group is presented in Table 6.  It 
should be noted that one subject in the CON group did not complete the baseline 
maximal graded treadmill test due to not being comfortable only breathing through her 
mouth during the test.  Therefore, only data for 9 subjects (CON, n=9) were used in the 
final analysis. No significant group differences inVO2peak existed at baseline.  Repeated-
measures ANOVA failed to detect any significant main effects for time or group x time 
interactions for VO2peak.      
Table 6. VO2peak Before and After Training.
Group
Variable BFR (n=11) WALK (n=10) CON (n=9)
VO2peak (ml/kg/min) Pre 39.2 ± 1.0  38.3 ± 1.9  37.6 ± 1.3
Post 39.3 ± 1.4 37.2 ± 1.4  35.2 ± 1.9
Values are mean ± SE. BFR: Blood Flow Restriction, WALK: Walking only, CON: 
 Non-exercise Control.  
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 Group percent changes in VO2peak from baseline are depicted in Figure 6.  One-
way ANOVA failed to detect any significant group differences in percent change of 
VO2peak from baseline. 
 
Bone Characteristics of the Tibia 
 Bone characteristics of the Tibia 4% site at baseline and post-training for each 
group are presented in Table 7.  Cortical bone measurements were not analyzed for this 
site, as the distal tibia is composed primarily of trabecular bone.  Therefore, only total 
and trabecular bone area, content, and volumetric bone mineral density (vBMD) are 
reported.  Baseline vitamin D intake was negatively correlated (r=-0.35 to -0.53, 
p<0.05) to several of the tibia bone variables, and was therefore used as a covariate.  No 
significant group differences at baseline existed among any of the tibia 4% site 
variables.  No significant group x time interaction effects were detected for any of the 
tibia 4% variables, and this remained true after adjusting for vitamin D intake.  
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However, a significant main effect for time was found for trabecular bone content 
(p=0.036) and trabecular vBMD (p=0.024), both of which decreased over the study 
duration.   Percent changes from baseline in the tibia 4% site bone variables for each 
group are presented in Table 10. No significant differences in percent change from 
baseline were detected for any of the tibia 4% bone variables.        
Table 7. Bone Characteristics at the 4% Tibia Site Before and After Training. 
Group
Variable    BFR (n=11)  WALK (n=10)  CON (n=10)
Tibia 4%
 Tot Bone Content (mg/mm) Pre  334.6 ± 17.8   364.1 ± 28.1   349.3 ± 19.9
Post 315.6 ± 16.5   360.5 ± 25.5   331.6 ± 14.5
 Tot vBMD (mg/cm3) Pre 305.666 ± 18.620   316.490 ± 17.597   315.360 ± 11.171
Post 295.773 ± 10.217   305.490 ± 19.777 304.150 ± 9.613
 Tot Bone Area (mm2) Pre 1101.50 ± 30.16 1151.31 ± 61.38 1109.41 ± 50.76
Post 1065.40 ± 33.94 1183.92 ± 43.33 1096.34 ± 47.81
 Trab Bone Content (mg/mm) + Pre   263.2 ± 13.9   290.8 ± 22.1   279.5 ± 19.7
Post   249.3 ± 15.8   285.6 ± 19.9   260.8 ± 14.1
 Trab vBMD (mg/cm3) + Pre   275.618 ± 17.567   291.260 ± 16.718   285.340 ± 11.173
Post   264.836 ± 11.617   277.610 ± 17.977 271.270 ± 7.765
 Trab Area (mm2) Pre   964.79 ± 33.51 1004.48 ± 58.80   976.40 ± 48.36
Post   937.85 ± 30.19 1034.85 ± 43.74   963.68 ± 46.01
Values are mean ± SE. Tot: Total, Trab: Trabecular, vBMD: Volumetric Bone Mineral Density.
BFR: Blood Flow Restriction, WALK: Walking only, CON: Non-exercise Control.+ Significant time effect.  
 Bone characteristics of the tibia 38% and 66% sites at baseline and post-training 
for each group are presented in Tables 8 and 9, respectively.  Trabecular bone 
characteristics were not analyzed for the tibia 38% and 66% sites, as these sites are 
composed primarily of cortical bone tissue.  Therefore, only total and cortical bone 
content, vBMD, and area as well as cortical shell thickness, periosteal and endosteal 
circumference, and strength strain index (SSI) are reported.  There were no significant 
baseline group differences for any of the tibia 38% and 66% variables.  No significant 
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group x time interaction effects were detected for any of the tibia 38% and 66% 
variables, and this remained true after adjusting for baseline vitamin D intake.  
However, significant time effects were found for total bone content (p=0.036) and SSI 
(p=0.011) at the 38% site as well as total bone content (p=0.043), total vBMD 
(p=0.029), total bone area (p=0.001), periosteal circumference (p=0.002), and endosteal 
circumference at the 66% site.  Total vBMD at the 66% site decreased post-training, 
whereas the other variables with significant time effects increased over the study 
duration.  Percent changes from baseline in the tibia 38% and 66% site bone variables 
for each group are presented in Table 10.  No significant differences in percent change 
from baseline were detected for any of the tibia 38% or 66% bone variables. 
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Table 8. Bone Characteristics at the 38% Tibia Site Before and After Training. 
Group
Variable    BFR (n=11)  WALK (n=10)  CON (n=10)
Tibia 38%
 Tot Bone Content (mg/mm) + Pre     292.3 ± 8.1     320.7 ± 12.9     312.6 ± 8.4
Post     294.6 ± 7.4     323.9 ± 11.3     314.0 ± 8.8
 Tot vBMD (mg/cm3) Pre  911.800 ± 14.075  916.140 ± 25.319  923.880 ± 10.619
Post  914.218 ± 13.666  924.140 ± 21.842  925.640 ± 9.586
 Tot Bone Area (mm2) Pre    321.27 ± 10.12    350.05 ± 10.50    338.88 ± 10.49
Post    322.98 ± 9.23    350.93 ± 10.43    339.70 ± 10.53
 Cort Bone Content (mg/mm) Pre      278.2 ± 7.8      307.8 ± 12.3      300.4 ± 8.3
Post      280.5 ± 6.9      310.9 ± 10.5      301.7 ± 8.6
 Cort vBMD (mg/cm3) Pre 1183.418 ± 5.579 1197.300 ± 6.362 1185.720 ± 6.823 
Post 1185.218 ± 5.853 1197.360 ± 5.929 1187.550 ± 4.448
 Cort Area (mm2) Pre     235.35 ± 7.44     257.25 ± 10.68    253.41 ± 6.91
Post     236.87 ± 6.51     259.88 ± 9.33    254.05 ± 7.04
 Cort Thickness (mm) Pre         4.90 ± 0.13         5.16 ± 0.23        5.18 ± 0.09
Post         4.92 ± 0.13         5.21 ± 0.20        5.18 ± 0.09
 Periosteal Circ (mm) Pre       63.46 ± 1.02        66.26 ± 0.99       65.19 ± 1.00
Post       63.64 ± 0.92        66.34 ± 0.97       65.27 ± 1.00
 Endosteal Circ (mm) Pre       32.67 ± 1.12        33.85 ± 1.46       32.66 ± 0.92
Post       32.70 ± 1.14        33.54 ± 1.45       32.70 ± 0.89
SSI (mm3)+ Pre    1282.28 ± 54.34     1480.31 ± 68.94    1403.43 ± 65.51
Post    1301.87 ± 48.90     1484.32 ± 70.51    1416.59 ± 62.47
Values are mean ± SE. Tot: Total, Cort: Cortical, vBMD: Volumetric Bone Mineral Density, Circ: Circumference.  
BFR: Blood Flow Restriction, WALK: Walking only, CON: Non-exercise Control.+ p<0.05,  Significant time effect. 
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Table 9. Bone Characteristics at the 66% Tibia Site Before and After Training. 
Group
Variable    BFR (n=11)  WALK (n=10)  CON (n=10)
Tibia 66%
 Tot Bone Content (mg/mm) + Pre       337.3 ± 9.1        364.2 ± 11.1       358.7 ± 11.8
Post       339.5 ± 8.9        364.6 ± 10.8       359.5 ± 11.7
 Tot vBMD (mg/cm3) + Pre    714.491 ± 14.625    755.460 ± 26.658   728.050 ± 14.100
Post    708.364 ± 14.517    752.730 ± 25.796   723.580 ± 13.724
 Tot Bone Area (mm2) + Pre      473.56 ± 14.21      486.46 ± 18.99     494.34 ± 18.70
Post      480.48 ± 13.41      488.40 ± 18.40     498.80 ± 19.69
 Cort Bone Content (mg/mm) Pre        309.2 ± 8.5        336.5 ± 10.9       329.9 ± 10.9
Post        310.2 ± 8.5        336.5 ± 10.6       329.7 ± 10.4
 Cort vBMD (mg/cm3) Pre  1157.282 ± 6.346   1170.660 ± 3.723  1155.800 ± 5.821
Post  1159.173 ± 5.372   1170.310 ± 3.931  1151.130 ± 6.087
 Cort Area (mm2) Pre      267.26 ± 7.63       287.41 ± 9.21      285.36 ± 8.96
Post      267.74 ± 7.60       287.55 ± 9.04      286.37 ± 8.61
 Cort Thickness (mm) Pre         4.19 ± 0.11           4.53 ± 0.17          4.40 ± 0.10
Post         4.15 ± 0.11           4.52 ± 0.17          4.39 ± 0.10
 Periosteal Circ (mm) + Pre       77.05 ± 1.17         78.05 ± 1.55        78.69 ± 1.47
Post       77.63 ± 1.09         78.21 ± 1.50        79.04 ± 1.54
 Endosteal Circ (mm) + Pre       50.73 ± 1.36         49.56 ± 2.23        51.03 ± 1.55
Post       51.56 ± 1.24         49.81 ± 2.18        51.03 ± 1.55
 SSI (mm3) Pre    1999.00 ± 73.65 2136.94 ± 100.98     2162.79 ± 111.88
Post    2029.62 ± 71.25 2148.82 ± 104.04     2162.27 ± 119.56
Values are mean ± SE. Tot: Total, Cort: Cortical, vBMD: Volumetric Bone Mineral Density, Circ: Circumference.  
BFR: Blood Flow Restriction, WALK: Walking only, CON: Non-exercise Control.+ p<0.05, Significant time effect.  
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Table 10. Percent changes in Tibia 4%, 38%, and 66% Site Bone Characteristics.
Group
BFR WALK CON
Variable 4% 38% 66% 4% 38% 66% 4% 38% 66%
Tot Bone Content ‐4.7 ± 3.3 0.9 ± 0.5 0.7 ± 0.3 0.2 ± 3.8 1.3 ± 1.2 0.1 ± 0.2 -4.2 ± 2.4 0.4 ± 0.3 0.3 ± 0.3
Tot vBMD ‐1.7 ± 3.0 0.3 ± 0.3 -0.8 ± 0.7 -3.7 ± 1.9 1.0 ± 0.9 -0.3 ± 0.2 -3.2 ± 2.0 0.2 ± 0.3 -0.6 ± 0.3
Tot Bone Area ‐3.3 ± 1.2 0.6 ± 0.6 1.5 ± 0.7 4.8 ± 5.4 0.3 ± 0.2 0.5 ± 0.3 -1.0 ± 0.6 0.3 ± 0.2 0.9 ± 0.4
Trab Bone Content ‐5.1 ± 3.2 -0.5 ± 4.2 -5.4 ± 2.9
Trab vBMD ‐2.5 ± 3.1 -4.8 ± 2.2 -4.3 ± 2.5
Trab Area ‐2.7 ± 1.0 5.3 ± 6.5 -1.2 ± 0.6
Cort Content 1.0 ± 0.5 0.4 ± 0.5 1.3 ± 1.3 0.0 ± 0.3 0.4 ± 0.4 0.0 ± 0.4
Cort vBMD 0.2 ± 0.4 0.2 ± 0.2 0.0 ± 0.1 0.0 ± 0.1 0.2 ± 0.3 -0.4 ± 0.3
Cort Area 0.8 ± 0.8 0.2 ± 0.5 1.3 ± 1.3 0.1 ± 0.2 0.2 ± 0.3 0.4 ± 0.3
Crt Thickness 0.6 ± 0.6 -0.9 ± 0.9 1.6 ± 1.5 -0.3 ± 0.2 0.1 ± 0.2 -0.2 ± 0.3
Periosteal Circ 0.3 ± 0.3 0.8 ± 0.3 0.1 ± 0.1 0.2 ± 0.1 0.1 ± 0.1 0.4 ± 0.2
Endosteal Circ 0.1 ± 0.3 1.7 ± 0.9 -0.8 ± 0.8 0.6 ± 0.3 0.2 ± 0.2 0.7 ± 0.3
SSI 1.8 ± 0.9 1.7 ± 0.9 0.3 ± 0.4 0.5 ± 0.3 1.1 ± 0.6 -0.1 ± 0.8
Values are mean ± SE. Tot: Total, Cort: Cortical, vBMD: Volumetric Bone Mineral Density, Circ: Circumference, Trab: Trabecular,
BFR: Blood Flow Restriction, WALK: Walking only, CON: Non-exercise Control.
   
Dietary Analysis 
 Average daily total caloric intake, protein intake, calcium intake, and vitamin D 
intake for week one and week twelve were determined using three-day dietary food 
logs. Average daily nutrient intake data for weeks 1 and 12 for each group are presented 
in Table 11.  No significant group differences in any of the nutrient intake variables 
existed at week one.  No significant group x time interaction effects were detected for 
any of the nutrient intake variables.  However, a significant (p=0.008) time effect was 
found for average daily total calorie intake, where daily caloric intake decreased over 
the study duration.  Figure 7 depicts the group changes in average daily total caloric 
intake from week 1 to week 12.  There was a significant group effect for percent change 
in total caloric intake (p=0.034) with BFR and WALK being significantly different 
(BFR: -20.9 ± 4.5% vs. WALK: 2.3 ± 6.8%).  The CON group only showed a slight 
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percent decrease in total caloric intake post-training (-5.8 ± 6.9%).  All groups had an 
average daily intake of calcium and vitamin D during week 1 and week 12 below the 
average recommended daily allowance of 1000 mg/day and 600 IU/day, respectively, 
set forth by the Institutes of Medicine (96).  However, these estimates are based on 
intake from the diet only. Vitamin supplementation was not documented by the three-
day food log and sun exposures were not accounted for.   
Table 11. Average Daily Nutrient Intake during Week 1 and 12.
Group
Variable BFR (n=11) WALK (n=10) CON (n=9)
Total Calories (kcal)+ Pre 2157.8 ± 148.1  1973.5 ± 213.7   1892.9 ± 135.1
Post 1688.7 ± 138.9 1939.4 ± 178.9 1714.7 ± 85.3
Total Protein (g) Pre 73.5 ± 7.9 69.2 ± 6.3   72.9 ± 5.8
Post 64.5 ± 4.7 64.8 ± 6.4   67.7 ± 5.1
Calcium (mg) Pre 600.7 ± 86.1  694.1± 96.5     829.6 ± 169.1
Post 530.7 ± 50.2  612.1± 96.5   606.5 ± 97.6
Vitamin D (IU) Pre   53.4 ± 18.9   35.0 ± 19.5     66.8 ± 20.4
Post   31.6 ± 12.5   41.1 ± 16.6     75.3 ± 28.7
Values are mean ± SE. BFR: Blood Flow Restriction, WALK: Walking only, CON:
Non-exercise Control. + Significant time effect.  
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DISCUSSION 
 The main objective of the current study was to assess the effects of 12 weeks 
walking with blood flow restriction on serum markers of bone turnover 
(formation/resorption) in college-aged women.  Additionally, sub-objectives were to 
examine changes in muscle strength, calf and thigh MCSA, aerobic capacity, and bone 
characteristics of the tibia following the 12-week intervention.  While the efficacy of 
BFR exercise to potentiate beneficial neuromuscular adaptations is well known, data on 
its skeletal effects are lacking.  Recently, our group (71) published a report regarding 
the potential osteogenic effects of low-intensity BFR exercise based on the few existing 
data in the literature as well as potential mechanisms that might be provided by the 
blood flow restriction stimulus.  However, the conclusions of our report pointed toward 
a need for further BFR exercise interventions aimed at determining its role in skeletal 
health and adaptation, especially in female populations.  To date, only three studies 
have examined the chronic bone turnover response to BFR exercise, two utilizing low-
intensity resistance training with BFR (53, 55) and one with BFR treadmill walking 
(10).  Moreover, none of these investigations used a female population, which is of 
significant interest when discussing skeletal health.  In their position stand on physical 
activity and bone health, the American College of Sports Medicine recommends 
activities such as moderate to high-intensity resistance training as well as weight-
bearing activities of high-impact (e.g. jumping, hopping etc.) to maintain or augment 
bone accrual(57).  In this regard, an alternative mode of exercise such as walking with 
BFR could potentially provide an attractive option for populations not able to perform 
the high-impact exercise that is currently recommended for bone health. To the best of 
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the author’s knowledge, this is the first intervention in college-aged women designed to 
evaluate the bone metabolism response to walking with and without blood flow 
restriction. 
Serum Markers of Bone Turnover 
 Structural bone changes from exercise occur at a relatively slow rate compared 
to other tissues such as skeletal muscle.  For this reason, interventions designed to study 
structural bone changes require durations > 6 months.  However, serum markers of bone 
turnover respond much sooner to stimuli and help to explain changes in overall bone 
metabolism.  In order for these markers to be clinically useful, it is important to 
understand what factors can affect their pre-analytical variability including the 
menstrual cycle, feeding status, caloric energy deficits, time of year (seasonal), age, 
gender, and acute physical activity (107) .  Therefore, it is imperative that as many of 
these factors are controlled for when evaluating changes over an intervention period.  In 
the current study, only women taking combined oral contraceptives were included, 
specifically to help control for the fluctuations in bone turnover markers that have been 
reported to occur during the normal menstrual cycle (126).  To help minimize the acute 
effects of feeding, physical activity, and diurnal fluctuations, blood samples were 
collected after an overnight fast between the hours of 8:00 and 10:00AM on both 
collection days.  Additionally, the post-training blood sample was collected at least 48 
hours after the last exercise session.   
 In the current study, the bone turnover markers Bone ALP (formation marker) 
and TRAP5b (resorption marker) were measured at baseline and post-training to 
determine the effects of walking with BFR on bone turnover.  Additionally, Bone ALP 
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to TRAP5b ratio was calculated as an index of overall bone metabolism. Significant 
changes in resting serum concentrations of Bone ALP were observed after the 12-week 
intervention (Table 2).  Specifically, post hoc analyses found that both the BFR and 
CON groups experienced a reduction in serum Bone ALP concentrations following the 
intervention with no change in the WALK group.  With regards to percent change from 
baseline, only the CON group was significantly different from WALK or BFR (-9.8%, 
1.9%, -5.8%) groups (Figure 1).  No significant changes were observed for serum 
TRAP5b or the ratio of Bone ALP to TRAP5b.  The results of this study are not in 
agreement with two of the three published studies on changes in markers of bone 
turnover following chronic BFR exercise.  After 3 weeks (6 days/week) of twice-daily 
walking with and without BFR, Beekley and colleagues (10)  reported a significant 
increase (10.8%) in resting serum Bone ALP concentrations.  This change was only 
observed in the BFR group.  The lack of agreement in results between the study by 
Beekley and colleagues and the current study may be related to differences in 
methodologies.  Beekley and colleagues (10) had their subjects walk two times per day 
at a speed of 50 m/min (< 3 mph) for five, two-minute bouts with one-minute rest 
periods between bouts.  The subjects in the current study walked continuously for up to 
20 minutes at a speed (3.0-3.8 mph) associated with an intensity of 45% VO2peak.  Even 
though the subjects in the current study were walking at a higher intensity, it is possible 
that the inserted rest periods between bouts may account for the different Bone ALP 
response.  It is well established that rest periods inserted between mechanical loading 
cycles amplify the bone loading response and that longer duration loading desensitizes 
bone cells, acutely (94, 106).  Also of importance is the difference in BFR pressures 
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employed.  The study by Beekley et al. (10) started and ended with a higher pressure 
stimulus (160-230 mmHg) than was used in the current study (140-180 mmHg).  
Because restriction pressure and the degree of arterial occlusion is highly related to 
thigh circumference and underlying tissue composition (70), it is likely that the lower 
occlusion pressures used in our female participants, who likely have smaller thigh 
circumferences, produced a similar stimulus to the pressures used in the male subjects 
of Beekley and colleagues (10).     
 Similar to the results reported by Beekley and colleagues (10), Karabulut and 
colleagues (53) reported significant increases in resting serum concentrations of Bone 
ALP following six weeks of low-intensity (20% 1RM) resistance training with blood 
flow restriction in older men.  Also reported was a significant increase in the ratio of 
Bone ALP to CTX, indicative of a shift in bone metabolism favoring bone formation.  
Similar to the results of our study, no change in bone resorption markers were observed.  
It is difficult to directly compare the results of the current study to those of Karabulut 
and colleagues (53), especially since the modes of exercise are different (resistance 
training vs. walking) as well as the inherent biological differences in bone turnover 
markers that arise with age (old vs. young).  
 While both the studies by Beekley and colleagues (10) and Karabulut and 
colleagues (53) found significant increases in bone formation markers following BFR 
exercise, the results of the current study may have been influenced by other factors 
outside of the exercise protocol.  While the utmost care was taken in the design of the 
current study to minimize outside factors that could potentially affect the outcomes of 
bone turnover markers, it is possible that the reduction in Bone ALP concentrations 
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observed in this study were influenced by seasonal and dietary effects.  It is well 
documented that higher concentrations of serum markers of bone formation are 
generally observed during the winter months than summer months, which is thought to 
be associated with changes in serum vitamin D during these times (40, 119).  The 
baseline blood samples in this study were obtained in mid-late February and post-
training samples were obtained in mid-late May.  The significant decrease in Bone ALP 
concentration observed in the non-exercise control group could be related to this 
seasonal effect.  Furthermore, evidence from the 3-day food logs suggest that caloric 
energy balance was not maintained over the duration of the study, with the BFR group 
consuming approximately 400 calories/day less in week 12 compared to week 1 (Table 
9).  This finding is further supported by a loss in body weight in the BFR group 
following the 12-week intervention, albeit statistically non-significant (Figure 2).  It is 
well established that short-term caloric restriction and weight loss significantly alters 
bone formation markers.  Ihle and Loucks (50) conducted a study on energy availability 
and bone turnover in exercising young women and found that bone formation markers 
were significantly decreased by 10% following 8 days of caloric restriction that resulted 
in 2 kg loss of body weight.  In this study, it could be argued that the treadmill walking 
may have provided a beneficial bone turnover effect since the WALK group did not 
experience a weight reduction or a seasonal reduction in Bone ALP concentrations.  
Furthermore, the potential beneficial effect of treadmill walking on negating the 
seasonal reduction in Bone ALP in the BFR group could be masked by the effects of the 
caloric energy deficit and weight loss. However, we do understand that there are 
limitations to the dietary data collected in this study.  The 3-day food logs used to 
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estimate daily nutrient intakes were only administered twice, once during week one and 
gain in week 12 of the intervention.  Furthermore, we can only assume that participants 
were accurate and complete in filling out their food logs, which unfortunately, failed to 
take into account outside supplementation.          
Muscle Strength               
 Several studies have investigated the effects of BFR walking on muscular 
strength adaptations. However, the current study is the first to report changes in 
neuromuscular strength following BFR walking in young women. Following 12 weeks 
of training, isometric knee extension strength at joint angles of 30 and 60 degrees 
significantly increased over time (Table 4), with no differences between groups. 
However, the BFR group significantly increased 1RM knee extension strength post-
training, with no differences in CON or WALK groups.  Similarly, the BFR group had a 
significantly greater percent change (4.5%) in 1RM knee extension strength compared 
to CON (-1.9%) post-training (Figure 6).  No significant changes post-training were 
observed for isometric or 1RM knee flexion strength.  Similar changes in muscle 
strength have been reported in other investigations of BFR walking utilizing different 
study populations.   
 Ozaki and colleagues (82, 83) conducted two recent studies evaluating the 
effects of 10 weeks walking with and without BFR.  Both studies, one in male and 
female older adults (n=23) and one in older women only (n=18), used identical exercise 
protocols (20 minutes walking at 45% heart rate reserve, four days/week for 10 weeks, 
BFR pressure:140-200 mmHg) which were very similar to the protocol used in our 
study.  In the study using only older women, a significant time effect was reported for 
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isometric knee extension strength, whereas only the BFR group had a significant 
increase in dynamic knee extension (8%) and flexion (22%) muscle strength compared 
to the walking only control group.  Our results are strikingly similar to these, with the 
only exception being that we did not observe a significant increase in dynamic knee 
flexion.  In the other study by Ozaki et al. (82) in older men and women, only dynamic 
muscle strength of the knee flexors significantly increased (15%) in the BFR group with 
no difference in dynamic knee extension strength.  It should be noted that dynamic knee 
flexion in our study increased from baseline by almost 5% in the BFR group, whereas 
the WALK and CON groups experienced a 0.5% and -0.4% percent change from 
baseline, respectively.  However, these group differences were not statistically 
significant (p=0.08).  Taken together, the results of the current study and those by Ozaki 
et al. (82, 83) suggest that continuous treadmill walking at low-intensities (45% HRR, 
45%VO2peak) combined with BFR results in significant increases in lower body strength 
independent of age and gender.    
 Unlike the protocols mentioned above, Abe et al. (1) investigated the effects of 
non-continuous walking with and without BFR in young men. Their exercise sessions 
consisted of five two-minute walking bouts at a speed of 50 m/min with one-minute rest 
intervals between bouts.  Two exercise sessions were completed in one day (morning 
and afternoon), six days per week for 3 weeks (36 sessions total). The BFR group 
started at an exercise pressure of 160 mmHg on day one and increased by 10 mmHg 
each day until a final exercise pressure of 230 mmHg was reached.  Following the 
training intervention, the BFR walk group experienced significant increases in leg press 
(7.4%) and knee flexion (8.3%) 1RM strength as well isometric knee extension strength 
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(10.5%) with no post-training strength differences in the CON walk group.  Taken 
together, the results of both our study in young women and that of Abe et al. in young 
men seem to suggest that both continuous and non-continuous walking with BFR result 
in positive muscular strength adaptations.   However, it is worthwhile to mention that 
the durations of these studies were very different (12 weeks vs. 3 weeks).  Even though 
the study in young men was only three weeks in duration, the total number of exercise 
sessions was only slightly less than the total number of sessions in our study (36 
sessions vs. 48 sessions, respectively).  Overall, the results of our study combined with 
the other BFR walking studies provide evidence that beneficial adaptations in muscular 
strength can be achieved from low-intensity, functional exercise such as walking when 
combined with BFR independent of age and gender.   
Body Composition  
 Unlike the current study, significant increases in mid-thigh MCSA were 
reported in both of the aforementioned BFR walking studies conducted by Ozaki et al. 
(82, 83).  In their study in older women, the BFR walk group significantly increased 
MRI-derived mid-thigh MCSA by 3.1% with no change in the CON walk group.  
Similar improvements were seen in their study in older men and women, where the 
BFR walk group significantly increased MRI-derived mid-thigh MCSA by 3.2% 
following the training intervention. In the previously discussed study by Abe and 
colleagues (1) in young men, MRI-derived mid-thigh MCSA of the quadriceps and 
hamstrings significantly increased by 5.7% and 7.6%, respectively, in the BFR group 
with no change in the CON walk group. In an additional study by Abe et al. (2) in older 
men and women (n=19), estimated muscle-bone CSA  of the mid-thigh and proximal 
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calf (70% of the tibia bone length) were increased by 5.8% and 5.1%, respectively, 
following 6 weeks of 5 days/week (30 total sessions) BFR walking at 67 m/min 
(~45%HRR).  Each session was 20 minutes in duration employing the same progressive 
BFR pressures reported in the studies by Ozaki et al. (82, 83).  
 While each of the previously mentioned studies found significant improvements 
in mid-thigh MCSA after BFR walking, our study did not.  This is somewhat surprising, 
mainly because our exercise protocol is similar to those used in the majority of the other 
studies. With the exception of the study by Abe et al. (1) in young men that employed a 
non-continuous walking protocol of twice daily exercise sessions consisting of  five 
two-minute walking bouts at a lower intensity (50 m/min), our study and the others 
utilized continuous walking at a similar intensity (45%VO2peak vs. 45% HRR), exercise 
session duration (20 min), and training frequency (4-5 days/week).  One of the main 
differences between our study and the others was the BFR exercise pressures employed. 
Our study used an initial pressure of 140 mmHg, which was increased 20 mmHg every 
4 weeks with the final exercise pressure reaching 180 mmHg.  The studies by Abe et al. 
(2) and Ozaki et al. (82, 83) in older adults used an initial exercise pressure of 160 
mmHg which was increased every day by 10 mmHg until a final exercise pressure of 
200 mmHg was reached and used for the remainder of the study duration. Even higher 
pressures were used in the study by Abe et al. (1) in younger men, where initial exercise 
pressure started at 160 mmHg and was increased daily by 10 mmHg until a final 
pressure of 230 mmHg was reached.  It is possible that the more conservative restrictive 
pressures (140-180 mmHg) used in our study did not provide an adequate stimulus to 
the working musculature.  Prescription of BFR pressures and size of the BFR cuff used 
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are common limitations in the BFR exercise literature, and has been previously 
discussed in detail in a recent methodological paper (24).  Finally, it should be noted 
that the BFR group in our study had an estimated daily caloric reduction of 
approximately 400 kcal in week 12 compared to week one.  It is well documented that 
lean muscle mass accretion is influenced by energy availability (97), which could 
partially explain a lack of mid-thigh MCSA response in the BFR group.  Interestingly, 
we observed increases in MCSA at the tibia 66% site in both BFR and WALK groups.  
Only the study by Abe et al. (2) in older adults measured MCSA at a lower-leg site 
(70% of the tibial length) following BFR walking.  Estimated bone-muscle CSA 
significantly increased post-training by 5.1% in the BFR group.  However, their study 
did not employ a CON walking group as did ours.  The discrepancy between observed 
muscle hypertrophy in the lower leg musculature but not the upper leg may be related to 
the fact that we increased treadmill incline (2% grade) over the walking intervention as 
a form of progression.  Inclined treadmill walking has been shown to increase EMG 
muscle activity of the plantar flexors as well as power of the ankle joint compared to 
level walking (63).  Although we did not measure muscle activation in our study, it is 
possible that the increased grade of the treadmill resulted in greater activation and 
overload of the plantar flexors which contributed to the observed increases in calf 
MCSA in both the BFR and WALK groups following the training intervention.                    
Aerobic Capacity 
  Measures of aerobic capacity following BFR walking have been previously 
assessed in only a few studies.  To the best of our knowledge, this is the first study in 
young women to report changes in VO2peak following BFR walking exercise. Following 
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the 12-week intervention, VO2peak remained unchanged in all groups.  This finding is in 
agreement with the previously discussed study by Abe et al. (2) in older adults, which 
also failed to observe improvements in estimated peak oxygen uptake following six 
weeks of continuous BFR walking at an intensity of 45% HRR.  In contrast, the 
previously discussed study by Ozaki et al. (83) in older women reported a significant 
increase in estimated peak oxygen uptake following 10 weeks of walking with and 
without BFR.  Although our study and the other two were conducted at similar exercise 
intensities, baseline measures of aerobic capacity were lower in the subjects of the study 
by Ozaki et al. (83), suggesting that baseline cardiovascular fitness was worse compared 
to our subjects and those of Abe et al. (2).  Therefore, it is likely that an intensity of 
45% HRR was a large enough stimulus to evoke significant improvements in estimated 
peak oxygen uptake in this population.                 
Tibia Bone Characteristics 
 To the best of the author’s knowledge, this is the first study to present changes 
in bone characteristics of the tibia following BFR exercise.  Although changes in the 
cortical measurements of the tibia after only 12 weeks is unlikely, we hypothesized that 
changes in the 4% trabecular site may be possible due to the higher metabolic activity 
associated with this type of bone tissue.    
 The current study did not find any significant group differences in any of the 
tibia bone variables following the intervention.  However, several time effects were 
observed at each tibia site.  At the tibia 4% site, trabecular bone content and trabecular 
vBMD both decreased over the study duration (Table 7).  Recently, two studies have 
reported longitudinal data on young women characterizing trabecular bone changes in 
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the distal tibia.  Both Lauretani et al. (62) and Riggs et al. (92) observed significant 
yearly decreases in trabecular vBMD in women between 20-29 years over a three and 
six-year period.  Our results are in line with these findings, as total bone mineral content 
and trabecular vBMD both significantly decreased over the intervention period.  In 
contrast, a recent study by Lester et al. (68) reported significant increases in trabecular 
vBMD at the tibia 4% site following eight weeks of exercise training.  In their study, 
subjects were assigned to one of four groups: high-intensity resistance training, 
moderate-high-intensity aerobic training, resistance and aerobic training, or non-
exercise control.  After training 3 days/week for 8 weeks, the aerobic training group 
increased trabecular vBMD by 1.3% with no changes in the other groups.  Interestingly, 
these results did not resemble the changes they observed in bone turnover markers, as 
only the resistance training and combined training groups had a significant increase in 
bone formation markers.  These authors also noted that the results should be interpreted 
with caution, as their observed trabecular vBMD change was within their measurement 
error.  At the very least, it seems the exercise mode and intensity employed in our study 
was not sufficient to counter-act the age-related loss in trabecular vBMD shown in the 
previously mentioned longitudinal studies.  Our results must also be interpreted with 
caution, as the length of our intervention was likely too short to reach a full bone 
remodeling cycle (57).   
 At the cortical rich 38% site, total bone content and SSI increased following the 
12-week intervention (Table 9).  At the 66% site, we observed increases in total bone 
content and area as well as periosteal and endosteal circumference (Table 10).  In 
contrast, total vBMD at the 66% site decreased over time.  Taken together, these 
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changes are indicative of what has previously been reported in longitudinal studies 
characterizing changes in the diaphyseal sites of the tibia in young women.  Recently, a 
six-year longitudinal study  by Lauretani et al. (62) reported that significant periosteal 
and medullary expansion occurred in women between 20-29 years of age.  Our results 
are consistent with their findings, as we observed an increase in total bone area and 
periosteal and endosteal circumference.  Furthermore, these bone changes are in line 
with the changes we observed in calf MCSA in both exercise groups.  The relationship 
between muscle and bone has been known for some time, as muscle contractions are 
considered one of the major bone loading stimuli (34).  Therefore, it is reasonable to 
suggest that the changes in calf MCSA combined with the significant time effects for 
increases in MVC strength, may in part explain the changes in cortical expansion 
observed at the 66% site.  As with the findings from the 4% site, these bone changes 
should be interpreted with caution for several reasons.  The changes we observed are 
relatively small (Table 10), and most fall within our measurement precision for 
detecting a real change.  Furthermore, 12 weeks is a relatively short period of time for 
investigating changes in whole bone tissue.  It should be pointed out that the design of 
the study was not based on measuring whole bone changes, as this was only a secondary 
purpose.  Future studies examining the effects of BFR exercise on organ-level changes 
should be at least doubled in duration.        
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 CHAPTER V 
CONCLUSIONS 
 The purpose of this study was to investigate the effects of 12 weeks of walking 
with and without blood flow restriction on metabolic markers of bone turnover in 
college-aged women.  A secondary purpose of the study was to assess changes in thigh 
and calf MCSA, muscular strength, aerobic capacity, and cortical and trabecular bone 
characteristics of the tibia following the 12-week intervention.  The following research 
questions were addressed: 1) Will 12 weeks of treadmill walking with and without 
blood flow restriction significantly alter the resting serum levels of the bone turnover 
markers Bone ALP and TRAP5b? 2) Will 12 weeks of walking with and without blood 
flow restriction result in increased thigh and calf MCSA and leg bone free lean body 
mass? 3) Will 12 weeks of walking with and without blood flow restriction result in 
increased lower body strength? 4) Will 12 weeks of walking with and without blood 
flow restriction result in increased aerobic capacity? 5) Will 12 weeks of walking with 
and without blood flow restriction result in significant changes in bone characteristics of 
the tibia? 
Research Hypothesis 1. 12 weeks of treadmill walking with blood flow restriction 
but not without will result in significantly elevated levels of Bone ALP.  Resting 
levels of TRAP5b will not change following 12 weeks of treadmill walking with or 
without blood flow restriction. 
 No, the results do not support the hypothesis for changes in Bone ALP.  Resting 
serum concentrations of Bone ALP significantly decreased in the BFR group and did 
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not change in the WALK only group. However, TRAP5b did not change in either group 
as hypothesized. 
Subhypothesis 1. 12 weeks of walking with blood flow restriction will result in 
increased calf and thigh MCSA and Leg LM, with no changes from walking 
without blood flow restriction. 
 No, the results of the study do not support this hypothesis. The BFR and WALK 
groups both significantly increased calf MCSA.  No changes in thigh MCSA occurred 
in either the BFR or WALK only groups. 
Subhypothesis 2. 12 weeks of walking with blood flow restriction will result in 
increased lower body strength, with no changes from walking without blood flow 
restriction. 
 Yes, the results of the current study support this hypothesis. The BFR group 
significantly increased knee extension 1RM strength.  Additionally, significant time 
effects occurred for MVC knee extensions at joint angles of 30 and 60 degrees.  No 
changes in knee flexion 1RM or MVC strength occurred in any group.  
Subhypothesis 3. 12 weeks of walking with blood flow restriction will result in 
increased aerobic capacity but will remain unchanged following 12 weeks of 
walking without blood flow restriction. 
 No, aerobic capacity did not change in either group following the intervention. 
Subhypothesis 4. 12 weeks of walking with blood flow restriction will result in 
positive bone adaptations at the distal tibia site with no change after 12 weeks of 
walking without blood flow restriction. 
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This hypothesis was not supported.  No beneficial adaptations occurred at the 4% tibia 
site in the BFR group following the intervention. 
Significance of the Study 
 The results of the current study suggest that walking with BFR does not cause 
favorable adaptations is resting serum levels of bone turnover markers in young women 
taking combined oral contraceptives.  However, there were some potential unforeseen 
factors that might have affected the levels of bone turnover markers including caloric 
restriction/weight loss over the 12-week intervention as well as potential seasonal 
effects from starting the protocol in the winter and ending toward the beginning of 
summer. Walking with BFR did result in beneficial neuromuscular adaptations 
including increased muscle strength of the knee extensors and increased MCSA of the 
plantar flexor muscles.  Populations undergoing rehabilitation or severely deconditioned 
individuals could benefit from this functional form of exercise with regards to 
neuromuscular adaptations.  However, there is not enough evidence from the current 
data to recommend its use for skeletal health.   
Future Research  
 Research into the potential skeletal benefits of BFR exercise should not cease 
because of the results of this study.  There is good evidence from research in young men 
and older adults that there is potential for positive bone adaptations to occur from 
exercise with BFR.  Future research may want to examine resistance training as the 
primary mode of exercise used in conjunction with BFR to test its effects on bone 
metabolism and organ-level bone changes in women across the age span.  In addition, 
proper exercise prescription following the known rules for bone adaptation to loading 
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(short bouts with rest periods) should be considered when designing BFR studies aimed 
at improving the bone response. Lastly, great care must be taken to control for known 
factors that contribute to pre-analytical variability in bone turnover markers to ensure 
that the changes are related to the intervention.  In addition, nutrient intake should be 
more tightly regulated so that weight loss does not occur over the intervention.  The 
current study only used a 3-day food log at two time points over the twelve week 
intervention.  Future studies could assess nutrient intake more often as well as assess 
weight change at several intervals throughout the intervention.  Lastly, BFR pressures 
need to be considered.  It is likely that the prescribed pressures need to be 
individualized to the person rather than the population.  However, further research in 
this area is needed.    
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Verbal Recruitment Script 
Hello, my name is ------------, and I am a graduate student in the Department of Health 
and Exercise Science at the University of Oklahoma. I am inviting you to participate in 
a research study we are conducting. The title of the study is “The effects of 12 weeks 
walking with and without blood flow reduction on bone metabolic markers in young 
women.”  We are specifically looking for women between the ages of 18-30 years who 
are not currently exercising more than 2 days per week and are taking a combined oral 
contraceptive pill. We are performing this research study to determine if combining 
blood flow reduction with walking impacts bone health, muscle mass, strength, and 
aerobic fitness in women ages 18-30 years.  Blood flow reduction during exercise is a 
new training technique using specially designed cuffs (5 cm width) which are placed 
around the most upper portion of each leg and are inflated to reduce blood flow during 
exercise. 
 
You will be randomly assigned to one of three groups: low-intensity treadmill walking 
with blood flow reduction, low-intensity treadmill walking control, or a non-exercise 
control group. 
 
The total time commitment for this study is 14 weeks.  The two exercise groups will 
train 4 times/week for 12 weeks with each session lasting about 25 minutes. All three 
groups will be measured at 2 time intervals (baseline and post-training). During pre and 
post testing, we will measure your bone density, lower-body strength, lean and fat body 
mass, thigh and calf muscle cross-sectional area, aerobic fitness, and you will have your 
blood sampled by a trained phlebotomist.  
 
The pre and post testing sessions will involve exposure to low-dose radiation (DXA and 
peripheral quantitative computerized tomography) to obtain measures of muscle mass, 
fat, bone density, and thigh and calf muscle cross-sectional area.  
 
There is a possibility of mild soreness because of the testing and exercise, but any 
discomfort should be gone within a couple of days. Additionally, there may be some 
discomfort and mild subcutaneous bruising associated with the blood draws which will 
be performed by a nurse or trained phlebotomist. Monetary compensation for your 
participation is available.  
 
I would be happy to answer any questions that you may have about the study. 
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E-mail Message 
 
I am inviting you to participate in a research study we are conducting in the Department 
of Health and Exercise Science. The title of the study is “The effects of 12 weeks 
walking with and without blood flow reduction on bone metabolic markers in young 
women”. We are specifically looking for women between the ages of 18-30 years who 
are not currently exercising more than 2 days per week and are taking a combined oral 
contraceptive pill. We are performing this research study to determine if combining 
blood flow reduction with walking impacts bone health, muscle mass, strength, and 
aerobic fitness in women ages 18-30 years. Blood flow reduction during exercise is a 
new training technique using specially designed cuffs (5 cm width) which are placed 
around the most upper portion of each leg and are inflated to reduce blood flow during 
exercise. 
  
If you decide to participate, you will be randomly assigned to one of three groups: low-
intensity treadmill walking with blood flow reduction, low-intensity treadmill walking 
control, or a non-exercise control group.   
 
The total time commitment for this study is 14 weeks.  The two exercise groups will 
train 4 times/week for 12 weeks with each session lasting about 25 minutes. All three 
groups will be measured at 2 time intervals (baseline and post training). During pre and 
post testing sessions, we will measure your bone mineral density, lower body strength, 
lean and fat body mass and percentage, thigh and calf muscle cross-sectional area, 
aerobic fitness, and you will have your blood sampled by a trained phlebotomist. The 
testing sessions will involve exposure to low-dose radiation (DXA and peripheral 
quantitative computerized tomography) to obtain measures of muscle mass, fat, bone 
density, and thigh muscle cross-sectional area.  
 
There is a possibility of mild soreness because of the testing and exercise, but any 
discomfort should be gone within a couple of days. Additionally, there may be some 
discomfort or mild subcutaneous bruising at the site of the blood draws which will be 
performed by a nurse or trained phlebotomist.   
 
Thank you for your consideration to participate in our study. Monetary compensation is 
available for participation in this study. If interested or have further questions, please 
contact Kaelin Young (kcyoung@ou.edu). 
 
 “The OU IRB has approved the content of this message but not the method of 
distribution. The OU IRB has no authority to approve distribution by mass email.” 
 
 
Warm Regards, 
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Appendix B 
Initial Screening Checklist 
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Appendix C 
Informed Consent and Authorization to Use or Disclose Protected Health Information 
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Appendix D 
Study Questionnaires 
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Appendix E 
IRB Approval Letter 
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Appendix F 
Exercise Protocol 
 
Week Time to set 
exercise 
pressure 
Exercise 
Pressure 
(mmHg) 
Treadmill 
Elevation 
Treadmill 
Speed  
(mph) 
Exercise 
Duration 
Wk 1 ~3 min ~140  0% 3.0 – 3.8 10 min 
Wk 2 ~3 min ~140  0% 3.0 – 3.8 15 min 
Wk 3 ~3 min ~140  0% 3.0 – 3.8 20 min 
Wk 4 ~3 min ~140  0% 3.0 – 3.8 20 min 
Wk 5 ~3 min ~160  1% 3.0 – 3.8 20 min 
Wk 6 ~3 min ~160  1% 3.0 – 3.8 20 min 
Wk 7  ~5 min ~160  1% 3.0 – 3.8 20 min 
Wk 8 ~5 min ~160 1% 3.0 – 3.8 20 min 
Wk 9 ~5 min ~180 2% 3.0 – 3.8 20 min 
Wk 10 ~5 min ~180 2% 3.0 – 3.8 20 min 
Wk 11 ~5 min ~180 2% 3.0 – 3.8 20 min 
Wk 12 ~5 min ~180 2% 3.0 – 3.8 20 min 
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Appendix G 
Raw Data 
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